+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 34776

Chapter 34776 contains a list of PDF Full Texts available from EurekaMag.





Levinson, Harold, N., 2002:
Dysmetric dyslexia screening procedure administered on the internet

Mohide, P.T.; Huggins, M.J.; Ramsay, J.A.; Woulfe, J.; Provias, J.; Chorneyko, K.; Nowaczyk, M.J.M., 1999:
Dysmorphic facial features, CNS abnormalities, hand malformations, and myocardial cytomegaly in three female fetuses A familial fetal neurodegenerative disorder?

Perrotta, C.S.; Zingale, A.; Grossfeld, P.D.; Jones, C.; Ragusa, A.; Mattina, T., 2003:
Dysmorphic features in 37 patients with the Jacobsen Syndrome

Koduru, P.R.K.; Orner, S.; Yenamandra, A.; Tepperberg, J.H.; Bialer, M.G., 2001:
Dysmorphic features in two neonates with mosaic ring chromosome syndromes

Li, M.M.; Jackson, K.E.; Kim, K.C.; Andersson, H., 2002:
Dysmorphic features, extra chromosome material and multi-color FISH

Heshka, T.; Chorneyko, K.; Brennan, B.; Nowaczyk, M.J.M., 1999:
Dysmorphic features, multiple congenital anomalies, and preaxial polydactyly of feet Diabetic embryopathy or a malformation syndrome?

Mathern, G.W.; Cepeda, C.; Flores Hernandez, J.; Klapstein, G.J.; Calvert, C.R.; Jokel, E.; Mendoza, D.; Lalezarzadeh, K.; Levine, M.S., 2000:
Dysmorphic neurons show intrinsic electrophysiological and anatomical abnormalities in pediatric cortical dysplasia tissue

Olcay, L.; Okur, H.; Tuncer, M.; Erekul, S.; Yetgin, S., 1999:
Dysmorphic neutrophils in idiopathic thrombocytopenic purpura and the effect of steroids to increase dysmorphism and cause tetraploid macropolycytes

Kalter, H., 2001:
Dysmorphogenesis and oxidative stress in diabetic rats

Gelowitz, D.L.; Rakic, P.; Goldman Rakic, P.S.; Selemon, L.D., 2001:
Dysmorphogenesis in fetally irradiated non-human primates Implications for schizophrenia

Hunter, E.S.; Rogers, E.H., 1999:
Dysmorphogenic effects of three metabolites of haloacetic acids in mouse embryo culture

Blackston, R.D.; Coles, C.D.; Kable, J.A.; Howell, K.K.; Bertrand, J.; Meeks, B.; Haar, J., 2001:
Dysmorphological analysis of fetal alcohol syndrome clinic referrals A report of 300 cases receiving multidisciplinary evaluation

Blackston, R.D.; Kable, J.A.; Coles, C.D.; Meeks, M.E., 2002:
Dysmorphological diagnosis of fetal alcohol syndrome in two ethnic groups African-Americans and Caucasians

Henley, K.M.; Maria, B.L.; Braddock, S.R., 2003:
Dysmorphology and anthropometry in Joubert syndrome

Robin, N.H.; Alt, A.A.; Salbert, B.; Ellison, L.; Minnes, S.; Singer, L., 2002:
Dysmorphology associated with in-utero cocaine exposure

Kelani, A.I.; Abdel Naser, M.A.; Fadel, M.A.; Hassan, A.A., 2000:
Dysmotility like dyspepsia Clinical, gastric emptying and antral histopathological study

Giorgetti, G.M.; Tursi, A.; Brandimarte, G.; Rubino, E.; Gasbarrini, G., 2000:
Dysmotility-like dyspeptic symptoms in coeliac patients: role of gluten and Helicobacter pylori infection

Ayotte, J.; Peretz, I., 2000:
Dysmusia a developmental disability for music

Sztriha, L.; A.G.zali, L.; Wanders, R.J.A.; Nork, M., 1999:
Dysmyelination associated with abnormal plasmalogen synthesis due to peroxisomal isolated dihydroxyacetonephosphate acyltransferase deficiency

Yin, X.; Pioro, E.P.; Messing, A.; Trapp, B.D., 2000:
Dysmyelination in P0 overexpressing mice causes distal axonal degeneration

Utagawa, C.Y.; Kim, C.A.; Sugayama, S.M.M.; Bertola, D.; Oliveira, L.A.N.; Gonzalez, C.H., 1999:
Dysostosis spondylocostal A clinical study of 14 patients

PatelMohanakumara; NambiarSreejayan; VaidayanathanPriti; Ramesha,B.T.; GudasalamaniRavikanth; Ganeshaiah,K.N.; RameshVasudeva; JohnMohan; Santhoshkumar,T.R.; Mishra,P.D.; ViswakarmaRam; Shaanker,R.U., 2010:
Dysoxylum binectariferum Hookf , a rich source of rohitukine

Magazzù, G., 2001:
Dyspepsia: functional or not?

Hungin, A.P.S., 2002:
Dyspepsia: gaps between primary and secondary care

Lindberg, G.; Vieri, J., 2003:
Dyspepsia after withdrawal of omeprazole in healthy volunteers

Janetschek, P.; Gantert, F.; Boeckmann, U., 1999:
Dyspepsia and diet Impact of malabsorption

Stanghellini, V.; Tosetti, C.; De Giorgio, R.; Barbara, G.; Corinaldesi, R., 2002:
Dyspepsia and dyspepsia subgroups. Not all roads lead to Rome

Ahmad, N.A.; Metz, D.C., 1999:
Dyspepsia and heartburn

Meineche Schmidt, V.; Christensen, E., 1999:
Dyspepsia classification pocket chart based on symptoms in 7270 dyspepsia patients from general practice Evidence for two types of esophageal dyspepsia

Gremse, D.A.; Puente, P., 2002:
Dyspepsia in children who had gastroesophageal reflux disease as infants

Moncur, P.H.; Denyer, M.; Heatley, R.V., 1999:
Dyspepsia in clinical practice The benefits of a one-stop service

Numans, M.E.; Melker, R.A.; Hoes, A.W.; Wit, N.J., 2000:
Dyspepsia in primary care Prokinetic therapy or acid suppression? A randomized clinical trial

Nelson, D.B.; Murdoch, M.; Sandozi, I.K.; Dalmasso, A.P.; Crabtree, J.E.; Ho, S.B., 1999:
Dyspepsia in the community is associated with cagA-positive Helicobacter pylori

Schwartz, M.D.; Yedidia, M.J.; Pierre, M., 1999:
Dyspepsia in the inner city Patients beliefs and expectations

Sanaka, M.; Sakaki, N., 2001:
Dyspepsia is a predictor of ulcer relapse at the early stage of posteradication of Helicobacter pylori in patients with active gastric ulcer

Sundaram, K.; Rink, E.; Mendall, M.A., 2002:
Dyspepsia is more common in elderly women

Spiegel, B.M.; Vakil, N.B.; Ofman, J.J., 2001:
Dyspepsia management in primary care A reappraisal of competing strategies

Weijnen, C.F.; D.W.t, N.J.; Numans, M.E.; Quartero, A.O.; Verheij, T.J.M., 2000:
Dyspepsia management in primary care in the Netherlands, to what extent is Helicobacter pylori diagnosis and treatment incorporated?

Talley, N.J., 2002:
Dyspepsia management in the millennium: the death of test and treat?

Rabeneck, L.; Wristers, K.; Campbell, C.J.; Souchek, J.; Menke, T.; Wray, N., 2000:
Dyspepsia patients are not all the same Differences between VA and private practice settings

Craig, C.; Stuart, R.C.; Morran, C.; Burns, H.; Harden, K.; Power, A.; Walsh, D.; Morris, A.J., 2001:
Dyspepsia patients on therapy remain symptomatic with impaired quality of life

Tena Marsa, Xavier, 2000:
Dyspepsia treatment by the rheumatologis

Ramirez, F.C.; Holland, J.F.; Leung, F.W., 2002:
Dyspeptic patients exhibit abnormal duodenal mucosal defensive responses to topical application of HCl as measured by endoscopic reflectance spectrophotometry A prospective, randomized, controlled study

Portincasa, P.; Altomare, D.F.; Moschetta, A.; Venneman, N.G.; Kotsonis, T.; Palmieri, V.; Rinaldi, M.; Van Berge Henegouwen, G.P.; Palasciano, G., 1999:
Dyspeptic symptoms are associated with cholecysto-gastric and intestinal motility dysfunction in patients with chronic constipation

Samson, M.; Vermeijden, R.; Materns, E.; Smout, A., 2002:
Dyspeptic symptoms assessed during gastric emptying tests have a predictive value for the rate of gastric emptying in contrast to symptoms assessed at the outpatient clinic; A prospective study in 182 unselected patients with diabetes mellitus

Treiber, G.G.; Schwabe, M.; Ammon, S.; Walker, S.; Klotz, U.; Malfertheiner, P., 2002:
Dyspeptic symptoms associated with Helicobacter pylori infection Influence of strain and host specific factors

Pena, L.; Santana, M.; Marrero, J.M.; Sierra, A.; Ramos, J.C.; Orengo, J.C.; Aguiar, I., 2000:
Dyspeptic symptoms in children with and without Helicobacter pylori infection

Bode, G.; Brenner, H.; Adler, G.; Rothenbacher, D., 2001:
Dyspeptic symptoms in the older adults The role of Helicobacter pylori infection, and various demographic and life style factors

Jussila, Reijo, 2000:
Dyspetes praerogator , a new species and genus to Finland and Denmark

Potter, J.W.; Vaezi, M.F., 2001:
Dysphagia Is endoscopy for everyone too costly?

Fujishima, I., 2000:
Dysphagia: mechanism, treatment and rehabilitation

Sundar, N.; Pusalkar, A.; Rao, S.; Crimmins, R.; Swift, G.L.; Green, J.T., 2004:
Dysphagia Predictors for malignancy at endoscopy

Williams, L.; Dew, M.J., 2001:
Dysphagia Which test should be first

Langdon, D.E., 2001:
Dysphagia and Maloney dilations

Eisbruch, A.; Lyden, T.; Bradford, C.R.; Haxer, M.A.; Miller, M.A.; Teknos, T.N.; Chepeha, D.B.; Dawson, L.A.; Wolf, G.T., 2001:
Dysphagia and aspiration following radiation concurrent with chemotherapy for head and neck cancer Prospective study

Morris, D.L.; Ainsworth, A.; Leckenby, C.; Mcintyre, P.B.; Greenfield, S.M., 2003:
Dysphagia and the 2 week rule A hard act to swallow?

Lau, H., 2001:
Dysphagia aortica: harbinger of aortoesophageal fistula?

Goel, R.; Sampath, P.; Mikaelian, D.O., 1999:
Dysphagia caused by cervical osteophytes: three cases treated successfully by surgery

Ramanaden, D.N.; Bernard, M.S.; Srivastava, E.D.; Allison, M.C., 1999:
Dysphagia clinic Cost-efficient patient management A five year experience

Cremer, R.; Krakamp, B.; Peitz, G.; Blaeker, F.; Weiss, M., 2001:
Dysphagia due to tuberculous mediastinal lymphadenopathy and esophagitis

Shah, U.; Arshad, M.; Mozaffar, T., 1999:
Dysphagia in hereditary sensory autonomic neuropathy type IV

Jiménez-Alonso, J.; Estev, D.; Vera, C.; Sabio, Jé.Mario., 2003:
Dysphagia in patients with systemic lupus erythematosus

Vakil, N.B.; Zuckerman, S.; Levine, J.G., 2002:
Dysphagia in uncomplicated reflux disease

Uzunca, K.; Birtane, M.; Tezel, A., 2004:
Dysphagia induced by a cervical osteophyte: a case report of cervical spondylosis

Awad, Z.T.; Watson, P.; Smyrk, T.C.; Filipi, C.J., 2000:
Dysphagia is associated with intraepithelial eosinophils in esophageal biopsies

Heidelberger, D.; Heppner, J.B., 1999:
Dysphania numana biology in Queensland, Australia

Safabakhsh, S.; Parambi, V.; Lanser, M.; Madantschi, M.H., 2002:
Dysphonia among hemodialysis patients in Guam

Pineda, J.A.; Karns, C.; Vankov, A., 1999:
Dysphoria and decision-making Does mood affect making advantageous choices?

Woo, M.A.; Dracup, K.A.; Doering, L.V.; Brown, T.; Hamilton, M.A.; Fonarow, G.C.; Moser, D.K., 2000:
Dysphoria predicts morbidity and mortality in advanced heart failure patients

Tohen, M.; Baker, R.; Brown, E.; Schuh, L.; Trzepachz, P.; Dando, S., 2003:
Dysphoric mania A controlled study of the benefits of olanzapine combined with valproate or lithium

Sontag, S.J.; Schnell, T.G.; Chejfec, G.; Leya, J.; Aranha, G., 2001:
Dysplasia Negative for, indefinite for, and low grade have no prognostic value for Barretts cancer

Cooper, H.S.; Murthy, S.; Kido, K.; Yoshitake, H.; Flanigan, A., 1999:
Dysplasia and cancer in the dextran sulfate sodium mouse colitis model Relevance to human disease and the role of inflammation to dys/ca

Caruntu, I.D.aga; Dobrescu, G.; Floarea Strat, A.; Axinia, T., 2001:
Dysplasia and hyperplasia Dangerous lesions in Heliobacter pylori gastritis

Montgomery, E.; Bronner, M.; Goldblum, J.; Greenson, J.; Haber, M.; Lamps, L.; Lauwers, G.; Lazenby, A.; Lewin, D.; Robert, M.; Toledano, A.; Washington, K.; Hart, J., 2000:
Dysplasia as a predictive marker for cancer in Barretts esophagus A follow-up study based on consensus diagnoses in 151 cases from 10 institutions

Okonkwo, A.; Diaz, L.Jr; Musunuri, S.; Talamonti, M.; Weinrach, D.; Rao, S.M., 2001:
Dysplasia in Barretts esophagus Morphologic and molecular analysis

Rutter, M.D.; Wilkinson, K.H.; Saunders, B.P., 2003:
Dysplasia in ulcerative colitis is usually visible at colonoscopy

Lee, W.J.oung; Deane, N.G.; Parker, M.A.; Wada, M.; Saha, D.; Sheng, H.; Shao, J.; Washington, M.K.; Beauchamp, R.D., 1999:
Dysplasia of liver in LFABP-cyclin D1 transgenic mice

Brien, T.P.; Odze, R.D., 2000:
Dysplasia-like gastric epithelial changes secondary to chemoradiotherapy for esophageal cancer

Freire-Maia, N.; Ribeiro, E.M.S.F., 2002:
Dysplasias and malignancies

Ono, J.; Yamano, T., 2001:
Dysplasias of cerebral cortex: basic and clinical aspects

Mully, T.; Tam, S.; Kamino, H., 2001:
Dysplastic changes in halo nevi A study of 103 cases

Carcangiu, M.L.; Radice, P.; Spatti, G.; Pasini, B., 2002:
Dysplastic changes of the fallopian tubes in BRCA-1 and BRCA-2 germline mutation carriers at prophylactic oophorectomy

Attard, T.M.; Abraham, S.; Giardiello, F.M.; Cuffari, C., 2001:
Dysplastic changes within fundic gland polyps A longitudinal hospital based analysis

Demarquay, G.; Guenot, M.; Ryvlin, P.; Mauguiere, F., 2001:
Dysplastic cortex can remain functional in epileptic malformations of cortical development

Haferlach, T.; Schoch, C.; Loeffler, H.; Gassmann, W.; Schnittger, S.; Sauerland, M.C.; Ludwig, W.D.; Buechner, T.; Hiddemann, W., 2001:
Dysplastic features in 614 patients with de novo acute myeloid leukemia Frequency, correlation to cytogenetic results and prognostic impact

Huang, J.; Mikami, Y.; Melamed, J., 1999:
Dysplastic lesions in multifocal renal oncocytomas

Salinas, S.; Simon, R.S.; Tejerina, E.; Perez Mies, B.; Cuevas, J.; Contreras, F., 1999:
Dysplastic melanocytic nevus Clinicopathological features

Talos, D.M.; Black, P.M.; Jensen, F.E., 2003:
Dysplastic neurons in cortical tubers express selective alterations in AMPA and NMDA receptor subunits

Shors, A.R.; Kim, S.; White, E.; Piepkorn, M., 2003:
Dysplastic nevi in persons with malignant melanoma A matched case-control Study

Park, Y.N.; Bae, S.H.; Byun, B.H.; Yoon, S.K.; Jung, E.S.; Baek, J.H.; Byun, J.Y.; Kim, D.G.; Chung, K.W.; Sun, H.S.; Park, D.H.; Kim, B.S., 1999:
Dysplastic nodules are prevalent among cirrhotic livers with hepatocellular carcinoma Analysis in 24 explanted cirrhotic livers

Koskinas, J.; Petraki, K.; Rapti, I.; Hadziyannis, S.J., 2000:
Dysplastic/premalignant liver cell changes and hepatocellular proliferation in patients with HBV or HCV related cirrhosis

LeGrand, S.B., 2002:
Dyspnea: the continuing challenge of palliative management

Shrestha, M.; Shah, A.; Lettieri, C., 2010:
Dyspnea and dysentery: a case report of pleuropulmonary amebiasis

Gonzalo Garijo, M.A.; Perez Calderon, R.; Albendiz Ruiz, V., 2001:
Dyspnea and stridor as presenting symptoms of thyroglossal duct cyst in an adult

Willeput, R.; Service, D.K.nesitherapie D.C.T.A.R., 1999:
Dyspnea and voluntary hypoventilation

Teerlink, J.R., 2003:
Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure

Hashim, M.S.; Shevde, K., 1999:
Dyspnea during interscalene block after recent coronary bypass surgery

Cade, S.; Anselme Martin, F.; Raszka, F.; Pons, M.; Davy, J.M.; Messner Pellenc, P., 1999:
Dyspnea threshold is related to ventilatory threshold during exercise in patients with chronic heart failure

Gielen, S.; Riedel, B.; Adams, V.; Linke, A.; Schuler, G.; Hambrecht, R., 2003:
Dyspnea-induced training of the diaphragm augments local antioxidative enzyme activity in an animal model of heart failure Implications for aerobic metabolism

Gielen, S.; Adams, V.; Riedel, B.; Linke, A.; Schuler, G.; Hambrecht, R., 2003:
Dyspnea-induced training of the diaphragm augments local antioxidative protection in an animal model of heart failure

Yernault, J.C., 2001:
Dyspnoea in the elderly: a clinical approach to diagnosis

Sheng, X.Y.ng; Hambidge, M.; Lei, S.; Westcott, J.; Miller, L.; Krebs, N., 2004:
Dysprosium as a non-absorbable fecal marker in studies of zinc homeostasis

D.L.P.na, L.S.rrano; Billings, P.C.; Shore, E.M.; Kaplan, F.S., 2002:
Dysregulated BMP4 signaling in FOP lymphocytes

Mccartney Francis, N.; Mizel, D.; Wahl, S., 1999:
Dysregulated IFN-gamma signaling pathways in TGF-beta1 deficient mice

Medvedev, A.E.; Lentschat, A.; Wahl, L.; Golenbock, D.T.; Vogel, S.N., 2002:
Dysregulated LPS-induced TLR4-MyD88 complex formation and IRAK-1 activation in endotoxin-tolerant human monocytes

Blackwell, T.S.; Stecenko, A.A.; Christman, J.W., 2001:
Dysregulated NF-kappaB activation in cystic fibrosis: evidence for a primary inflammatory disorder

Akdis, M.; Trautmann, A.; Disch, R.; Blaser, K.; Akdis, C.A., 2001:
Dysregulated T cell apoptosis in atopic dermatitis Mechanisms of increased survival in the skin

Liuzzo, G.; Biasucci, L.M.; Trotta, G.; Morlacchi, L.; Porto, A.; Santamaria, M.; Lomaglio, D.; Raimondi, F.; Rebuzzi, A.G.; Buffon, A.; Maseri, A.; Crea,, 2002:
Dysregulated T-cell function and acute phase response in patients with recurrent unstable angina

Hoyer, K.K.; Renard, M.; Weinger, J.G.; Teitell, M.A., 2003:
Dysregulated TCL1 promotes mature B cell lymphoma and increases TH2 cytokine secretion

Mcclain, C.J.; Barve, S.; Hill, D.; Deaciuc, I., 2000:
Dysregulated TNF/Fas signaling in alcoholic liver disease

Lohoff, M.; Bischof, S.; Prechtl, S.; Mittruecker, H.W.; Pahl, A.; Mak, T.W.; Ferrick, D., 2000:
Dysregulated Th1/Th2 differentiation in T helper cells deficient in IRF4

Halaban, R.; Cheng, E.; Smicun, Y.; Germino, J., 2000:
Dysregulated activity of E2F transcription factors in melanoma cells

Schwiebert, E.M.; Rice, W.C.; Taubman, P.D.; Haycraft, C.J.; Boyce, A.T.; Yoder, B.K., 2002:
Dysregulated amiloride-sensitive sodium transport in collecting duct epithelial monolayers derived from the orpk murine model of polycystic kidney disease

Frater, J.L.; Kay, N.E.; Goolsby, C.L.; Crawford, S.E.; Peterson, L.A.C., 2003:
Dysregulated angiogenesis in chronic lymphocytic leukemia Morphologic, immunohistochemical, and flow cytometric evidence

Balakrishnan, V.S.; Perianayagam, M.C.; Guo, D.; Jaber, B.L.; Murray, S.L.; King, A.; Pereira, B.J.G., 1999:
Dysregulated cytokine production by peripheral blood mononuclear cells in hemodialysis patients

Nawijn, M.C.; Cameron, S.B.; Lorrijnen, T.; Rothman, P.B.; Coffman, R.L.; Savelkoul, H.F.J., 2000:
Dysregulated differentiation of CD4+ T cells into effector phenotypes in SJA9 IgE low-responder mice

Kaempfer, H.; Braeutigam, L.; Geisslinger, G.; Pfeilschifter, J.; Frank, S., 2003:
Dysregulated expression and activity of cyclooxygenase-1 and -2 during diabetes-impaired wound healing

Garcia Rostan, G.; Rimm, D.L.; Herrero, A.; Carcangiu, M.L.; Tallini, G., 1999:
Dysregulated expression and mutation of b-Catenin in high grade thyroid carcinoma

Greene, L.M.; Twal, W.O.; Foley, D.A.; Duffy, M.J.; Argraves, W.S.ott; Gallagher, W.M., 2002:
Dysregulated expression and proteolysis of fibulin-1 in human breast tumors

Bryan, M.W.; Ringel, J.; Lin, M.F.ng; Batra, S.K., 2001:
Dysregulated expression of ADAM 9, 17 and TIMP-3 in human prostate carcinomas

Feldman, G.J.; Patel, R.; Billings, P.C.; Kingsley, D.M.; Shore, E.M.; Kaplan, F.S., 2002 :
Dysregulated expression of BMP5 in a patient with deformed helices, axial skeletal defects, and heterotopic ossification A clue from the short-ear mouse

Kongkanuntn, R.; Bubb, V.J.; Sansom, O.; Wyllie, A.H.; Harrison, D.J.; Clarke, A.R., 1999:
Dysregulated expression of beta-catenin in murine pancreatic and intestinal neoplasia

Djakiew, D., 2000:
Dysregulated expression of growth factors and their receptors in the development of prostate cancer

Neilson, L.J.; Stuart, R.C.; Stoeber, K.; Williams, G.; Going, J.J., 2000:
Dysregulated expression of minichromosome maintenance proteins 2 and 5 in esophageal squamous epithelium and Barretts mucosa

Millien, G.; Hinds, A.; Wang, J.; Cao, Y.X.; Williams, M.C.; Ramirez, M.I., 2003:
Dysregulated expression of p21 and PCNA in lungs lacking the epithelial type I cell gene T1alpha links type I cell differentiation to cell cycle control in distal lung during alveolus formation

Shuto, T.; Furuta, T.; Harada, K.; Suico, M.A.n; Kai, H., 2004:
Dysregulated expression of toll-like receptors in human cystic fibrosis epithelial cells

Ing, R.; Stevenson, M.M., 2002:
Dysregulated immune responses in interleukin 15-deficient mice to blood-stage malaria infection

Mcclain, C.J.; Hill, D.B.; Marsano, L.S.; Pena, L.R.; Kugelmas, M.; Barve, S., 2001:
Dysregulated interleukin 18 metabolism in alcoholic liver disease and non-alcoholic steatohepatitis

Rivera Reyes, B.M.; Danese, S.; Sans, M.; Fiocchi, C.; Levine, A.D., 2004:
Dysregulated intracellular redox equilibrium in intestinal lamina propria T cells contributes to mucosal inflammation

Abrahamson, D.R.; S.J.hn, P.L.; Robert, B., 2000:
Dysregulated laminin synthesis in alpha3 collagen mutant mice

Harper, L.; Ren, Y.; Savill, J.; Adu, D.; Savage, C.O.S., 1999:
Dysregulated neutrophil apoptosis in systemic vasculitis

Barisoni, L.; Mokrzycki, M.; Sablay, L.; Nagata, M.; Yamase, H.; Kriz, W.; Mundel, P., 1999:
Dysregulated podocyte cell cycle in collapsing glomerulopathies

Dixon, D.A., 2004:
Dysregulated post-transcriptional control of COX-2 gene expression in cancer

Sicher, K.J.; Overman, K.M.; Sayed, B.A.; Coruh, B.; Matsumoto, S.; Cominelli, F.; Cohn, S.M.; Pizarro, T.T., 2001:
Dysregulated production of IEC-derived cytokines during early vs established disease in the SAMP1/Yit model of spontaneous ileitis

Schwiebert, E.; Boyce, A.T.; Liang, L.; Hanson, E.; Winkelbauer, M.; Zsembery, A.; Yoder, B.K., 2003:
Dysregulated transepithelial ion transport and signaling in collecting duct principal cell monolayers from a mutant orpk polycystic kidney disease mouse model lacking an apical central cilium

Frech, M.S.; Halama, E.; Tilli, M.T.; Gunther, E.; Chodosh, L.; Flaws, J.; Furth, P.A., 2004:
Dysregulating expression of Estrogen Receptor alpha in mammary epithelial cells results in developmental abnormalities and ductal hyperplasia

D.L.P.na, L.S.rrano; Billings, P.C.; Ahn, J.; Kaplan, F.S.; Shore, E.M., 2001:
Dysregulation of BMP receptor IA in fibrodysplasia ossificans progressiva

Richmond, A.; Kelley, T.; Hsi, E.; Tannenbaum, C.; Molto, L.; Finke, J.H., 2003:
Dysregulation of Bcl-2 expression in tumor infiltrating T lymphocytes

Martins, R.S.; Mullins, D.W.; Elgert, K.D., 2000 :
Dysregulation of CD40L expression contributes to tumor-induced Mphi dysfunction

Saberwal, G.; Hu, W.Y.ng; Janssen, I.; Galili, N.; Raza, A.; Mundle, S.D., 2002:
Dysregulation of E2F1 Activity in Myelodysplasia

Wang, S.; Pudney, J.; Song, J.; Mor, G.; Zheng, W., 2002:
Dysregulation of Fas/FasL system in endometrial hyperplasia

Miller, G.J.; Miller, H.L., 2000:
Dysregulation of HOXC gene expression in prostatic carcinoma

Freeman, J.W.; Nair, P.; Dearmond, D.; Strodel, W.E., 2000:
Dysregulation of IGF-1 receptor signaling mediates growth factor independence and resistance to apoptosis in MIA PaCa-2 cells

Ohshima, Yusei; Omata, Nemuko; Yasutomi, Motoko; Yamada, Akiko; Fujisawa, Kazuo; Mayumi, Mitsufumi, 2001:
Dysregulation of IL-13 production by cord blood CD4 T cells is associated with the subsequent development of atopic disease

Mathew, R.; Huang, J.; Shah, M.; Gewitz, M.H.; Sehgal, P.B., 2003:
Dysregulation of IL-6/caveolin-1/raft/STAT3 function in monocrotaline-induced pulmonary hypertension in rats

Schauenstein, K.; Felsner, P.; Steinschifter, W.; Schauenstein, E., 2000:
Dysregulation of IgG subclass biosynthesis associated with malignant disease

Ruan, X.Z.; Moorhead, J.F.; Powis, S.H.; Fernando, R.; Wheeler, D.C.; Varghese, Z., 2003:
Dysregulation of LDL receptor by an inflammatory cytokine A new pathway for foam cell formation in vascular smooth muscle cells

Tselepis, C.; Sharma, N.; Hardy, R., 2003:
Dysregulation of Myc network proteins in Barretts metaplasia

Hiscott, J.; Sharma, S.; Grandvaux, N.; Mamane, Y.; Azimi, N.; Lin, R., 2002:
Dysregulation of NF-kB and IRF signaling in HTLV-I induced T-cell leukemogenesis

Sharma, S.; Grandvaux, N.; Mamane, Y.; Azimi, N.; Lin, R.; Hiscott, J., 2003:
Dysregulation of NF-kappaB and IRF signaling in HTLV-I leukemogenesis

Masilamani, S.; Turner, P.L.; Reyes, I.; Dibona, G.; Knepper, M.A., 2000:
Dysregulation of Na transporters in a rat model of congestive heart failure

Suck, G.; Jiffar, T.; Konopleva, M.; Andreeff, M.; Ruvolo, P., 2003:
Dysregulation of PP2A activity by a mechanism involving suppressed PP2A a expression may result in chemoresistance in AML

Steppan, L.; Funatake, C.; Kerkvliet, N., 2004:
Dysregulation of T cell activation by the aryl hydrocarbon receptor

Scrivener, S.; Prentice, A.G.; Kaminski, E.R.; Demaine, A.; Kruger, A.R., 1999:
Dysregulation of T lymphocyte activation markers in B-cell Chronic Lymphocytic Leukaemia

Proud, V.K.; Aly, T.A.; Creswick, H.A.; Stacey, M.W., 2002:
Dysregulation of TGF-alpha and TGF-beta1 signaling proteins predict clinical features of Costello syndrome

Merritt, J.J.; Li, D.Q.; Lee, S.B.; Tan, D.T.; Tseng, S.C., 1999:
Dysregulation of TGF-betas and TGF-betaRs expression in pterygium head fibroblasts

Kim, Y.H.e; Nielsen, J.; Kwon, T.H.an; Madsen, K.M.; Wall, S.M.; Frokiaer, J.; Nielsen, S., 2002:
Dysregulation of acid/base transporters in rats with lithium-induced NDI

Kang, J.S.; Maygarden, S.J.; Kim, D.; Mohler, J.L.; Ornstein, D.K., 2001:
Dysregulation of annexin I protein expression in prostatic intraepithelial neoplasia and prostatic carcinoma

Kishore, B.K.; Lebrun, M.; Umanath, K.; Dilulio, D.; Krane, C.M.; Beauchamp, D., 2000:
Dysregulation of apical Na-K-2Cl cotransporter and AQP3 in renal medulla of rats treated with low dose gentamicin

Ouhtit, A.; Muller, H.K.; Ananthaswamy, H.N., 1999:
Dysregulation of apoptosis during UVB skin carcinogenesis in mice

Andreeff, M.; Konopleva, M.; Zhao, S.; Leysath, C.; Carter, B.; Milella, M.; Weidner, D.; Lapillonne, H.; Tabe, Y.; Schober, W.; Hu, W.; Heiss, P.; Estey, E.; Huang, Z.; Kornblau, S., 2001:
Dysregulation of apoptosis in AML New therapeutic opportunities

Talal, N.; Dang, H.; Long, L., 1999:
Dysregulation of apoptosis in Sjogrens syndrome

Leitch, D.; Barrans, S.L.; Jack, A.S.; Owen, R.G., 2003:
Dysregulation of apoptosis in Waldenstrom's macroglobulinemia does not involve nuclear factor kappa B activation

Garcia Rostan, G.; Camp, R.; Rimm, D.; Herrero, A.; Carcangiu, M.L.; Tallini, G., 2000:
Dysregulation of beta-CAT is associated with thyroid tumor progression and is critical for the development of undifferentiated carcinoma

Mayer, N.J.; Wong, N.A.C.S.; Mackell, S.; Gilmour, H.M.; Harrison, D.J., 2000:
Dysregulation of beta-catenin protein expression is a late but relatively infrequent event in ulcerative colitis-related colorectal carcinogenesis

Owesson, C.A.; Hopwood, S.E.; Callado, L.F.; Seif, I.; Mclaughlin, D.P.; Stamford, J.A., 2000:
Dysregulation of brain monoaminergic neurones in monoamine oxidase-A knockout mice

Mee, J.B.; Agnew, K.L.; Groves, R.W., 2003:
Dysregulation of caspase-1 recruitment domain proteins in psoriasis

Bol, D.K.; Dell, J.; Ho, C.P.; Swerdel, M.; Rowley, B.; Mulheron, J.G.; Webster, K.R., 2000:
Dysregulation of cdk 2 and cyclin E in the mouse skin Impacts on cell proliferation and tumorigenesis

Jeang, Kuan Teh, 1999:
Dysregulation of cell cycle checkpoint by the HTLV-I Tax protein

E.G.obashy, A.A.; Shaaban, A.M.; Herod, J.; Innes, J.; Prime, W.; Herrington, S., 2003:
Dysregulation of cell cycle control proteins during cervical glandular carcinogenesis

Schrader, A.J.; Hansen, W.; Pfoertner, S.; Goelden, U.; Buer, J.; Heidenreich, A.; Hofmann, R., 2004:
Dysregulation of cellular retinoic acid-binding protein -1 in renal cell carcinoma

Zhou, B.P.; Hung, M-Chie., 2003:
Dysregulation of cellular signaling by HER2/neu in breast cancer

Wu, Y.J.; Bi, Q.N.; Mount, H.T.J., 1999:
Dysregulation of cerebellar NF-kappaB in a mouse model of ataxia-telangiectasia

Reinhart, T.A.; Fallert, B.A.; Pfeifer, M.; Capuano, S., IIi; Rajakumar, P.; Murphey Corb, M.; Fuller, C.L.; Schaefer, T.M., 2002:
Dysregulation of chemokine expression in lymphoid tissues during SIV/DeltaB670 infection of rhesus macaques

Wolf, K.; Castrop, H.; Kurtz, A., 1999:
Dysregulation of chloride channel clc-K2 mRNA in the renal inner medulla of Dahl salt sensitive hypertensive rats

Ito, A.; Asagami, T.; Tsao, P.S.; Adimoolam, S.; Kimoto, M.; Tsuji, H.; Reaven, G.M.; Cooke, J.P., 1999:
Dysregulation of dimethylarginine dimethylaminohydrolase A mechanism of endothelial dysfunction in diabetes mellitus

Black, Y.; Eichenbaum, H.B.; Kantak, K.M., 2002:
Dysregulation of drug-seeking behavior following lidocaine inactivation of the lateral prefrontal cortex

Bing, C.; Tisdale, M.J.; Williams, G., 2002:
Dysregulation of energy balance in cancer cachexia

Cheng, X.; Mihindukulasuriya, K.; Den, Z.; Koch, P., 2004:
Dysregulation of genes encoding cytoskeletal and signal transduction proteins in desmocollin 1 mutant mice

SilvanI.A.; Bastianini, S.; Berteotti, C.; Franzini, C.; Lenzi, P.; L.M.rtire, V.; Zoccoli, G., 2010:
Dysregulation of heart rhythm during sleep in leptin-deficient obese mice

Holt, R.; Ralph, S.; Davies, J.; Lamb, W.; Webb, N.; Brenchley, P., 2003:
Dysregulation of heparanase in steroid sensitive nephrotic syndrome

Unlap, T.; Hwang, E.; Kovacs, G.; Peti-Peterdi, J.; Siroky, B.; Williams, I.; Bell, P.D., 2002:
Dysregulation of [Ca2+](i) in OK-PTH cells expressing a mesangial cell Na+/Ca2+ exchanger isoform from Dahl/Rapp salt-sensitive rats

Singh, R.; Cuchacovich, R.; Huang, W.; Jones, C.E.; Amos, J.; Espinoza, L.R., 2002:
Dysregulation of insulin receptor by insulin like growth factor-1 and insulin growth factor binding protein leading to hypoglycemia in SLE

Emamian, E.S.; Grandits, M.E.; Meyer, C.M.; Leiran, A.N.; Ermer, J.; Baechler, E.C.; Behrens, T.W.; Rhodus, N.L.; Moser, K.L., 2003:
Dysregulation of interferon inducible and aquaporin 1 genes in the blood of patients with Sjogrens syndrome

Fukui, K.; Watanabe, M.; Yajima, T.; Okamoto, S.; Yamazaki, M.; Ishii, H.; Hibi, T., 2000:
Dysregulation of interleukin-7 mediated immune responses in chronic inflamed mucosa of T cell receptor alpha chain mutant mouse

Grunze, H.C.; Langosch, J.; Walden, J., 2001:
Dysregulation of ion fluxes An underlying disturbance in bipolar affective disorder?

Zaki, M.H.; Shane, R.B.; Geng, Y.; Showe, L.C.; Presky, D.H.; Moore, J.S.; Rook, A.H., 2000:
Dysregulation of lymphocyte interleukin-12 receptor expression in Sezary syndrome

Klein, G., 2000:
Dysregulation of lymphocyte proliferation by chromosomal translocations and sequential genetic changes

Shedid, D.; Bojanowski, M.W.; Caron, J.L.; Beliveau, R., 2000:
Dysregulation of metalloproteinases expression in the central nervous system vascular malformations

Zink, M.C.ristine; Uhrlaub, J.L.; Dewitt, J.B.; Tarwater, P.M.; Barber, S.A., 2003:
Dysregulation of mitogen-activated protein kinase signaling pathways in SIV encephalitis

Omori, S.; Hida, M.; Fujita, H.; Takahashi, H.; Awazu, M., 2001:
Dysregulation of mitogen-activated protein kinases in murine polycystic kidney disease

Breen, C.P.; Cooper, A.C.; Vyas, B.; Kemeny, M.; Macdougall, I.C., 2000:
Dysregulation of monocyte-derived cytokine production in epoetin-resistant haemodialysis patients

Watanabe, M.; Hibi, T., 1999:
Dysregulation of mucosal IL-7 system induces chronic colitis in IL-7 transgenic mice and ulcerative colitis

Watanabe, M.; Ueno, Y.; Yajima, T.; Okamoto, S.; Hitotsumatsu, O.; Ezaki, T.; Yamazaki, M.; Hayashi, T.; Ishii, H.; Kanai, T.; Hibi, T., 1999:
Dysregulation of mucosal immune responses mediated by intestinal epithelial cell-derived IL-7 in colonic inflammation

Ni, Z.; Barton, C.H.; Vaziri, N.D., 2003:
Dysregulation of nitric oxide synthase in hypoxia-induced systemic hypertension

Varney, M.; Johansson, S.; Mosley, R.L.e; Singh, R., 2003:
Dysregulation of normal monocyte/macrophage function mediates malignant melanoma progression

Brown, V.L.; Harwood, C.A.; Kelsell, D.P.; Proby, C.M., 2003:
Dysregulation of p16INK4a and p14ARF tumour suppressor genes in the pathogenesis of cutaneous squamous cell carcinomas

Sonsalla, P.K.; Zeevalk, G.D.; Bernard, L.P.; Manzino, L., 2001:
Dysregulation of phosphorylation and effects on dopamine neurons in vitro and in vivo

Li, C.; Wang, W.; Knepper, M.A.; Nielsen, S.; Frokiaer, J., 2001:
Dysregulation of renal aquaporins and sodium transporters in response to 24 hours of unilateral ureteral obstruction

Xin, W.; Chinnaiyan, A.M.; Pienta, K.J.; Dhanasekaran, S.M.; Ingold, C.; Rubin, M.A., 2002:
Dysregulation of selected annexin family proteins is associated with prostate cancer progression

D.M.ura, M.C.; Pinto, R.P.; Santos, M.L.; Marinho, R.T., 2000:
Dysregulation of serum pro- and anti-inflammatory cytokines in hepatitis B virus infection

Morena, M.; Jaber, B.L.; Balakrishnan, V.S., 2002:
Dysregulation of signaling pathways for interleukin-10 by uremic plasma

Terris, J.M.; Wang, X.; Beutler, K.; Schooley, J.; Pamnani, M.B.; Knepper, M.A., 2001:
Dysregulation of sodium transporter and sodium channel proteins in the two-kidney, one-clip Goldblatt rat

Rosato, R.R.; Wang, Z.; Fisher, P.B.; Grant, S., 2000:
Dysregulation of the CDK-inhibitor p21CIP1 increases the susceptibility of human leukemia cells to mitochondrial dysfunction and apoptosis induced by the histone deacetylatase inhibitor sodium butyrate

Wang, Z.; Wang, S.; Fisher, P.B.; Grant, S., 1999:
Dysregulation of the CDKI p21CIP1 inhibits human leukemic cell differentiation but promotes apoptosis following chronic exposure to low concentrations of ara-C

Hudlebusch, H.R.; Theilgaard Monch, K.; Johnsen, H.E.ik; Rasmussen, T., 2002:
Dysregulation of the MMSET Gene in Multiple Myeloma

Pflug, B.R.; Pecher, S.; Brink, A.K.; Nelson, J.B., 2003:
Dysregulation of the fatty acid metabolic pathway in the progression of prostate cancer

Neuen Jacob, E.; Kuckert, S.; Kuemmel, T., 2002:
Dysregulation of the glutamatergic system plays an important role in the pathogenesis of HIV dementia

Hayward, M.D.; Otero, V.; Refojo, D.; Arzt, E.; Reul, J.M.H.M.; Rubinstein, M.; Low, M.J., 1999:
Dysregulation of the hypothalamic-pituitary-adrenal axis after immunological stress in beta-endorphin deficient mice

Stafford, H.A.; Reichlin, M., 1999:
Dysregulation of the idiotype network in autoimmune diseases

Dalziel, H.H.; Pohler, E.; Craig, A.L.; Kernohan, N.; Hopwood, D.; Dillon, J.F.; Hupp, T.R., 2003:
Dysregulation of the major squamous cell stress responsive system in Barretts metaplasia

Hofer, M.D.; Kuefer, R.; Lin, H.; Ma, J.; Gschwend, J.E.; Sanda, M.G.; Chinnaiyanand, A.M.; Rubin, M.A., 2003:
Dysregulation of the metastasis-associated protein 1 in metastatic and clinically localized prostate cancer

Piboonniyom, S.; Timmermann, S.; Munger, K., 1999:
Dysregulation of the pRB pathway by cdk6 during oral carcinogenesis

Teerlink, J.R.; Gao, L.R.; Long, C.S.; Karliner, J.S., 1999:
Dysregulation of the transforming growth factor beta signaling pathway in rats with chronic heart failure

Kawaguchi, H.; Kobayashi, M.; Nakamura, K.; Takashi, S.; Konishi, N.; Miyagawa, S.I.hiro; Toyoda, H.; Komada, Y.; Kojima, S.; Katoh, O.; Ueda, K., 2001:
Dysregulation of transcription of primary granule enzymes during myeloid differentiation in patients with severe congenital neutropenia

Mahoney, E.J.; Reichner, J.; Mastrofrancesco, B.; Henry, W.; Albina, J.E., 2003:
Dysregulation of tumor necrosis factor in infected wounds of inducible nitric oxide synthase knockout mice

Wang, J.; Yu, S.; Liu, C.; Zhou, J.; Liu, Z.; Zhang, L.; Hsu, H.C.en; Mountz, J.D.; Zhang, H., 2004:
Dysregulation of ubiquitination and phosphorylation of AKT is essential for development of apoptosis resistance in rheumatoid synovial fibroblasts

Fuller, M.J.; Khanolkar, A.; Tebo, A.E.; Zajac, A.J., 2003:
Dysregulation of virus-specific T cell responses in chronically infected hosts

Curry, J.P.ul; Russell, M.W.; Hanna, C.M.; Devine, G.A., 2002:
Dysrhythmia, but Not Hypoxemia, Correlate Directly with ASA and ACC/AHA Stratification Systems during ECG Telemetry Stays

Harris, D.M.; Mills, G.D.; Chen, X.; Berretta, R.M.; Votaw, V.S.ott; Santana, L.F.; Houser, S.R., 2004:
Dyssynchronous SR Ca release contributes to depressed calcium transients in failing myocytes

Heinzel, F.R.; Bito, V.; Sipido, K.R., 2002:
Dyssynchronous subcellular Ca2+ release in pig ventricular myocytes

Kim, J.M.; Labree, L.; Levin, L.; Feldon, S.E., 2000:
Dysthyroid and Euthyroid Graves ophthalmopathy

Singh, M.; Kumar, A.; Sood, P.; Varshney, A.C.; Sharma, A., 2000:
Dystocia due to foetal anasarca in an Angora rabbit Anaesthetic and surgical management

Sharma, V.K.; Dabas, V.S.; Suthar, B.N., 2000:
Dystocia due to twinning in a goat and its management

Micke, G.C.; Sullivan, T.M.; Rolls, P.J.; Hasell, B.; Greer, R.M.; Norman, S.T.; Perry, V.E.A., 2010:
Dystocia in 3-year-old beef heifers; relationship to maternal nutrient intake during early- and mid-gestation, pelvic area and hormonal indicators of placental function

Misbahuddin, A.; Warner, T.T., 2001:
Dystonia: an update on genetics and treatment

Klein, C.; Ozelius, L.J., 2002:
Dystonia: clinical features, genetics, and treatment

Lehéricy, S.; Meunier, S.; Garnero, L.; Vidailhet, M., 2003:
Dystonia: contributions of functional imaging and magnetoencephalography

Meunier, S.; Lehéricy, Séphane.; Garnero, L.; Vidailhet, M., 2003:
Dystonia: lessons from brain mapping

Burchiel, K.J., 2004 :
Dystonia and deep brain stimulation

Burchiel, K.J.; Vayssiere, N.; Coubes, P., 2004:
Dystonia and deep brain stimulation - Response

Galvez Jimenez, N.; Lampuri, C.; Patino Piccirilo, R.; Hargreave, M., 2003:
Dystonia and headaches The response to botulinum toxin therapy

Rome, S.; Grunewald, R.A., 2000:
Dystonia and muscle fatigue

Vanek, Z.F.; Jankovic, J., 1999:
Dystonia in Corticobasal Ganglionic Gegeneration

Vanek, Z.F.; Jankovic, J., 2000:
Dystonia in corticobasal degeneration

Gruber, L.; Feichtinger, M.; Holl, A.; Schwingenschuh, P.; Wenzel, K.; Quasthoff, S.; Kleinert, G.; Koerner, E.; Ott, E., 2004:
Dystonia in epilepsia partialis continua successful treatment with botulinum toxine

Moretti, P.M.; Hedera, P.; Wald, J.J.; Fink, J.K., 2001:
Dystonia in two siblings from a consanguineous family Further evidence for autosomal recessive primary generalized dystonia

Lu, R.; Hurley, A.D.; Gourley, M., 2002:
Dystonia induced by mirtazapine

Vercueil, L.; Minotti, L.; Kahane, P., 2002:
Dystonia, mirror movement, and epileptic seizure

Rusu, V.; Chassoux, F.; Landre, E.; Bouilleret, V.; Nataf, F.; Devaux, B.C.; Semah, F., 2003:
Dystonic posturing in seizures of mesiotemporal origin Electroclinical correlations and metabolic patterns

Metzger, R.; Stehr, M.; Schuster, T.; Dietz, H.G.; Joppich, I., 2000:
Dystopic urethral orifice into the anus in the absence of the penile urethra and right kidney

Herzog, C.; Has, C.; Franzke, C-Werner.; Echtermeyer, F.G.; Schlötzer-Schrehardt, U.; Kröger, S.; Gustafsson, E.; Fässler, R.; Bruckner-Tuderman, L., 2004:
Dystroglycan in skin and cutaneous cells: beta-subunit is shed from the cell surface

Henry, M.D.; Campbell, K.P., 1999:
Dystroglycan inside and out

Heathcote, R.D.; Ekman, J.M.; Godfrey, E.W., 1999:
Dystroglycan overexpression decreases synaptic clustering of acetylcholine receptors at embryonic neuromuscular junctions

Edström, L., 1999:
Dystrophia myotonica. Clinical, pathophysiological and molecular aspects

Schlueter, A.; Makovitzky, J.; Rath, F.W., 2000:
Dystrophic amyloid of degenerated heart valves is glycosaminoglycan-associated

Chave, T.A.; Varma, S.; Knight, A.G., 2001:
Dystrophic calcinosis cutis in venous ulcers: a cause of treatment failure

Rucker Martin, C.; Pecker, F.; Godreau, D.; Hatem, S.N., 2001:
Dystrophic myocytes in fibrillating and dilated human atria An abnormal adaptative and growth process

Funke, S.; Morava, E.; Czako, M.; Cser, B.; Kosztolanyi, G.; Illes, T., 2002:
Dystrophic scoliosis and genetic polymorphisms in patients with neurofibromatosis

Montanez, C.; Romo Yanez, J.; Depardon, F.; Ceja, V.; Rendon, A.; Mornet, D.; Velazquez, F., 2003:
Dystrophin Dp71 isoforms expressed in PC12 cells Interaction between Dp71f and DGC

Pillers, D.A., 1999:
Dystrophin and the retina

Kanai, A.; Froehner, S.; D.G.oat, W.; Birder, L., 1999:
Dystrophin deficiency decreases nitric oxide production in skeletal myocytes, measured using a porphyrin sensor

Diong, D.; Knowlton, K.U., 2001:
Dystrophin deficiency markedly increases enteroviral cardiomyopathy A genetic predisposition to viral heart disease

Wang, X.; Xie, Y.; Zhang, C.; Liu, Z., 2002:
Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy

Abbs, S.; Smith, T.; Macleod, M.; Bobrow, M.; Mathew, C.; Muntoni, F.; Yau, S.C., 2000:
Dystrophin duplications Distribution, clinical significance, and somatic mosaicism

Rendon, A.; Bolanos Jimenez, F.; Strahle, U., 1999:
Dystrophin expression during eye development in the zebrafish

Leturcq, F.; Nudel, U.; Fuchs, O.; Deburgrave, N.; Zabot, M.; Recan, D.; Niel, F.; Kaplan, J.; Yaffe, D., 2001:
Dystrophin expression in cultured non-muscle fetal cells; possible applications for prenatal diagnosis

Qu, Z.; Huard, J., 1999:
Dystrophin expression in fast and slow muscles of MDX mice following normal myoblast transplantation

Rando, T.A.; Bertoni, C., 2002 :
Dystrophin gene repair in mdx muscle precursor cells mediated by RNA/DNA chimeric oligonucleotides

Law, R.; Liao, G.; Yang, Z.; Sweeney, H.L.e; Discher, D.E., 2004:
Dystrophin in forced extension Evidence of highly cooperative unfolding of multiple repeats under force

Vatta, M.; Jimenez, S.; Stetson, S.J.; Becker, K.; Torre Amione, G.; Bolwes, N.E.; Towbin, J.A., 2003:
Dystrophin normalization in right and left ventricle in end-stage cardiomyopathy and reverse remodeling after left ventricle assist device therapy

Jimenez, S.; Vatta, M.; Stetson, S.J.; Torre Amione, G.; Becker, K.; Bowles, N.E.; Towbin, J.A., 2003:
Dystrophin remodeling as molecular marker of heart failure in children with inherited cardiomyopathy

Bia, B.L.; King, L.M.; Sasson, S.; Rafael, J.A.; Davies, K.E.; Radda, G.K.; Clarke, K., 1999:
Dystrophin, but not utrophin, deficient mouse hearts have reduced glucose uptake due to decreased GLUT4 translocation

Ganote, C.E.; Armstrong, S.C., 2002:
Dystrophin-associated protein complex and heart failure

Rendon, A.; Bolanos Jimenez, F.; Pattnaik, B.; Bordais, A.; Balse, E.; Sahel, J.; Mornet, D.; Picaud, S., 2001:
Dystrophin-protein 260 is expressed in different cell types in the outer plexiform layer of the human retina Immunohistochemical and single cell RT-PCR analysis

Vila Torres, J.M.; Medina, M.; Clomer, J.; Iturriaga, C., 2000:
Dystrophinopaties Proposal of a semiquantitative method for reporting immunolabelling deficiencies in protein expresion

Howland, Howard, C., 1999:
Dysversion of the optic disc in presumed amblyopes

Paquette, D.; Alarie, Y., 1999 :
Dytiscid fauna in cattail ponds of northeastern Ontario, Canada

Anonymous, 1999:
E A Mukhin

Justino, M.C.; Costa, P.N.; Vicente, J.B.; Teixeira, M.; Saraiva, L.M., 2003:
E Coli flavorubredoxin, a novel type of nitric oxide reductase

Barnes, David, M., 2001:
E Coli lipopolysaccharide stimulates the expression of p-glycoprotein in the chicken liver, kidney and spleen

Zoh, Kyung Dukand Michael, K.Stenstrom, 1999:
E Fenton oxidation of high explosive RDX and HMX in aqueous solution

Bottomley, P.A.; Mansfield, P.; Allen, P.S., 2001:
E Raymond Andrew June 27, 1921-May 27, 2001

Majo, F.; Heuze Lecornu, L.; Montard, M.; Delbosc, B.; Schwartz, C.; Kantelip, B., 2000:
E cadherin and P53 expression in 15 conjunctival malpighian carcinoma , an immunohistochemical and clinical study

Griep, M.A.; Bhattacharyya, S.; Johnson, S.K., 2000:
E coli DnaB helicase stimulates E coli primase activity and alters its initiation specificity

Reyer, D.; Alexander, D.; Weis Klemm, M.; Aicher, W.K., 2003:
E coli LPS stimulates Interleukin 18 gene activity in synovial fibroblasts

Schultz, B.D.; Fahlman, D.K.; Carlin, R.W.; Gnad, D.P., 2002:
E coli LT and STa-stimulated intestinal secretion are differentially inhibited by K+ channel modulators in vivo and in vitro

Walker, Suzanne, 2001:
E coli MurG A paradigm for NRD1beta glycosyltransferases

Coia, J.E., 2003:
E coli O157 A pathogen of the developed world?

Cormican, M.; Morris, D.; Doran, G.; Corbett Feeney, G.; Flynn, J., 1999:
E coli O157, relative homogeneity of strains causing human infection in a predominantly rural population

Nwosu, V.C.; Dallas, T.; Ladapo, J., 2000:
E coli O157H7 Prevalence in ground beef from the Research Triangle area of North Carolina

Morgan, T.W.; Ackermann, M.R.; Gallup, J.M.; Dean Nystrom, E.; Moon, H., 2002:
E coli O157H7 colonization of 3-day-old, colostrum-fed pigs

Klopfenstein, T.J.; Smith, D.R.; Moxley, R.A.; Erickson, G.E.; Folmer, J.D.; Hinkley, S.; Macken, C.N., 2002:
E coli O157H7 intervention strategies for feedlot cattle

Tomova, I.; Georgieva, E.; Kantardjiev, T.; Staneva, S.; Christova, M.; Vajarova, P., 2003:
E coli O6 nosocomial outbreak in neontal intensive care unit

Viswanathan, A.; Liu, J.; Doetsch, P.W., 1999:
E. coli RNA polymerase bypass of DNA base damage. Mutagenesis at the level of transcription

Bedri, B.A.; Page, K.R.; Mcewan, G.T.A., 2000:
E coli STa enterotoxin and guanylin-induced Cl- secretion in isolated guinea-pig caecum is partially mediated by myenteric neurones

Huang, Y.H.i; Chang, H.C.ang; Chang, T.C.ain, 2004:
E coli agglutination assay

Haines, T.H.; Mileykovskaya, E.; Dowhan, W., 2001:
E coli contains cardiolipin patches Are they ox-phos units with a cardiolipin proton buffer?

Paul, M.S.; Arnqvist, A.; Boren, T.; Pussinen, P.; Bian, Z.; Normark, S.; Asikainen, S., 2003:
E coli curli -like proteins in Actinobacillus actinomycetemcomitans

Leverone, J.F.; Spooner, E.T.; Mori, C.; Weldon, D.A.; Lehman, H.; Clements, J.T.; Lemere, C.A., 2001:
E coli heat-labile enterotoxin dramatically increases anti-Abeta antibody titers following intranasal Abeta immunization in WT mice

Matsuzaki, G.; Takada, H.; Nomoto, K., 1999:
E coli infection induces fetal thymus-derived gamma/delta T cells

Lee, K.Y.; Perretta, S.G.; Zar, H.A.; Mueller, R.A.; Boysen, P.G., 1999:
E coli lipopolysaccharide endotoxin - Induced changes in plasma antioxidant capacity

Cho, L.S.; Wheeler, M.A.; Honig, S.C.; Smith, S.D.; Weiss, R.M., 1999:
E coli lipopolysaccharide increases nitric oxide synthase and myeloperoxidase activity in a rat epididymitis model

Bell, J.K.; Wright, S.K.rk; Viola, R.E.; Banaszak, L.J., 2000:
E coli malate dehydrogenase R153C Structural analysis of an active site mutant

Waugh, D.S.; Kapust, R.B.; Fox, J.D., 1999:
E coli maltose binding protein is uncommonly effective at inhibiting the aggregation of proteins to which it is fused

Inouye, M.; Inouye, S., 2000:
E coli msDNA synthesizing system, products and uses

Hong, T.; Moland, E.S.; Abdalhamid, B.; Hanson, N.D.; Wang, J.; Sloan, C.; Fabian, D.; Farajallah, A.; Levine, J.; Thomson, K.S., 2003:
E coli producing KPC-3 carbapenem hydrolyzing enzyme

Chowers, Y.; Matityahu, A.; Keller, N.; Bar Meir, S.; Goldway, M., 2002:
E coli secreting short chain variable fragments protect from intestinal salmonellosis

Bianchi, A.A.; Baneyx, F., 1999:
E coli stress promoters-LacACZ fusions for antibiotics detection

Drohat, A.C.; Jagadeesh, J.; Ferguson, E.; Stivers, J.T., 1999:
E coli uracil DNA glycosylase Ionization of the general-acid His187 examined by NMR, crystallography, mutagenisis, and pH-rate studies

Braileanu, G.T.; Panigrahi, P., 2003:
E coli-induced gene expression profiles in Caco-2 cells is changed by co-infection with Lactobacillus plantarum

Fure, H.; Christiansen, D.; Brekke, O.L.; Bergseth, G.; Lappegard, K.T.; Lambris, J.D.; Fung, M.; Mollness, T.E., 2001:
E coli-induced oxidative burst is complement dependent and can be abolished by different modes of complement inhibition

Christiansen, D.; Fure, H.; Bergseth, G.; Lambris, J.D.; Mollnes, T.E., 2001:
E coli-induced upregulation of granulocyte CR3 contributes to oxidative burst and is totally C5a receptor dependent

Ortona, E.; Margutti, P.; Vaccari, S.; Rigano, R.; Profumo, E.; Teggi, A.; Chersi, A.; Siracus, A., 2000:
E granulosus elongation factor B/D in allergic disorders associated with cystic echinococcosis

Zhu, J.S.i; Yin, W.; Wang, J.Y.n; Zhao, C.S.eng; Hong, Y., 2001:
E koreanum improves bone calcium and strength and hormones in animals

Marasini, B.; Casari, S.; Zeni, S.; Turri, O.; Guagnellini, E.; Biondi, M.L.isa, 1999:
E selectin polymorphism in autoimmune diseases

Araki, H.; Komoike, Y.; Suzuki, K.; Takeuchi, K., 2000:
E type prostaglandin inhibits indomethacin-induced gastric lesions through EP1 receptors A study using rats and knockout mice

Kunikata, T.; Takeeda, M.; Tanaka, A.; Kato, S.; Takeuchi, K., 2000:
E type prostaglandin inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors A study using rats and knockout mice

Mizoguchi, H.; Suzuki, K.; Sugawa, Y.; Araki, H.; Furukawa, O.; Takeuchi, K., 1999:
E type prostaglandins inhibit gastric lesions induced by indomethacin in rats through EP1 receptor subtype Relation to anti-gastric motility and neutrophil chemotaxis action

Lush, C.W.; Bauer, P.; R.Kvietys, P.; Russell, J.; Granger, D.N., 1999:
E- and P-selectin expression in the intestinal micro-vasulature after cecal ligation and perforation

Kim, I.; Boyle, K.M.; Carroll, J.L., 2003:
E-4031 sensitive current in rat carotid chemoreceptor type I cells decreases with age between birth and 11-16 days

Berger, J.J.; Elledge, M.C.; Kline, L.; Zimmerman, B.A.; Pringle, T., 1999:
E-54ARC and E-120ARC insulated shipping container validation process

Chilman Blair, K.; Leeson, P.A.; Bayes, M., 2003:
E-5564 Treatment of septic shock TLR4 receptor antagonist

Guitart, X.; Ballarin, M.; Codony, X.; Dordal, A.; Farre, A.J.; Frigola, J.; Merce, R., 1999:
E-5842 Antipsychotic sigma-receptor ligand

Guitart, X.; Zamanillo, D.; Andreu, F.; Farre, A.J., 1999:
E-5842, a potential atypical antipsychotic and sigma receptor ligand, regulates the mRNA expression of sigma1 and glutamate receptor subunits in rat brain

Alvarez, I.; Andres, E.; Buxens, J.; Colombo, M.; Fort, M.; Farre, A.J., 2001:
E-6259, a new potent and exceptional antiarthritic compound with COX-2 activity Pharmacologic profile

Ray, S.K.; Matzelle, D.D.; Wilford, G.G.; Hogan, E.L.; Banik, N.L., 2001:
E-64-d inhibited calpain mediated apoptosis and reduced immediate early gene expression and reactive astrogliosis in rat spinal cord injury

Anonymous, 2000:
E-7010 Oncolytic EN 185537

Reuter, H.; Goldhaber, J.I.; Philipson, K.D., 2001:
E-C coupling gain is reduced in transgenic homozygous NCX overexpressing mouse myocytes

Samayoa, L.M.; Lele, S.; Warren, G.W.; Musgrave, Y.M.; Cibull, M.L., 2002:
E-CADHERIN expression in the lobular component of Low Grade mammary carcinomas

Katyal, M.; Tiwari, S.C.; Kumar, A.; Dinda, A.K.; Das, N., 2002:
E-CR1 expression and polymorphism in Indian subjects

Lacy Colson, J.C.rlo Hattersley; Greenhough, A.; Sivakumar, R.; Deakin, M.; Hall, C.; Elder, J.B.own; Hoban, P.R.chard, 2003:
E-Cad promoter polymorphism effects clinical outcome in colorectal cancer

Lee, L.H.; Han, H.; Santucci, T.S.; Tung, M.Y.; Colonias, A.; Landreneau, R.J.; Silverman, J.F., 2002:
E-Cadherin expression as a prognostic marker differs in treated and untreated patients with adenocarcinoma of the esophagus

Nightingale, J.; Chaudhary, K.S.; Abel, P.D.; Stamp, G.W.; Lalani, E.N., 1999:
E-Cadherin expression is regulated by the androgen receptor in prostate cancer cell lines

Palacios, J.; Garcia Macias, M.C.; Bryant, B.; Sobel, M.E.; Merino, M.J., 2002:
E-Cadherin gene inactivation in pleomorphic lobular carcinoma of the breast

Qureshi, H.S.; Divine, G.; Linden, M.D.; Raju, U., 2003:
E-Cadherin in pleomorphic lobular carcinoma in situ and indeterminant carcinoma in-situ of breast

Naritoku, W.; Jones, L.W.; Imam, S.; Taylor, C.R.; Imam, S.A., 2002:
E-Cadherin is re-expressed on metastatic prostate cancer cells in bone

Hunter, Marilyn, 2000:
E-Commerce for the agricultural chemical industry

Allen, G.W.; Liu, J.; Kirby, M.A.; D.L.on, M., 2000:
E-FABP expression and localization in developing rat retina and dissociated retinal culture

Kim, D.; Yurkow, E.J.; Ripper, T.L.; Fox, T.L.; Young, S.H.; Gilotti, A.C.; Degeorge, G., 2003:
E-LLNA An enhanced, flow cytometry-based local lymph node assay with immunophenotype analysis

Lombardi, V.R.M.; Cacabelos, R., 1999:
E-SAR-94010 A marine fish extract obtained by advanced biotechnological methods

Biedermann, T.; Schwaerzler, C.; Kund, J.; Lametschwandtner, G.; Carballido Perrig, N.; Carballido, J., 2001:
E-Selectin dependent in vivo migration of atopic dermatitis derived Th2 cells through chemokine receptor 4 ligation

Schonholz, C.; Mendaro, E.; Sierre, S., 2000:
E-Trap A new device to prevent distal embolization during carotid percutaneous transluminal angioplasty and stenting

Pillai, S.D.; Espinosa, I.Y., 2003:
E-beam inactivation of RNA and DNA containing viruses

Krsko, P.; Stucchio, C.; Libera, M.; Clancy, R., 2002:
E-beam patterned poly for spatial control of surface bioactivity

Antoniou Lipfert, P.; Bockamp, E.; Oesch Bartlomowicz, B., 2004:
E-box and GATA-1 binding proteins are involved in the dioxin-dependent regulation of the SF-1 gene

Coulson, J.M.; Edgson, J.E.; Fiskerstrand, C.E.; Woll, P.J.; Quinn, J.P., 1999:
E-box motifs in the vasopressin promoter have enhancer activity in lung cancer

Ohno, K.; Brengman, J.M.; Engel, A.G., 2002:
E-box mutation in RAPSN promoter region causes endplate acetylcholine receptor deficiency

Allam, J.P.; Geiger, E.; Kraft, S.; Bieber, T., 2000:
E-cadherin A specific marker for in vitro generated Langerhans cells?

Heimann, R.; Ferguson, D.; Lan, F.; Mcbride, R.; Hellman, S., 1999:
E-cadherin The most significant prognostic marker in breast cancer patients with long follow-up

Goyal, A.; Jiang, W.G.; Mansel, R.E., 2003:
E-cadherin and alpha-catenin expression in relation to other prognostic factors and survival in human breast cancer

Rodrigues, C.F.leiro; Pinto, I.M.cedo; Pereira, D.; Coutinho, C.; Lopes, C., 2003:
E-cadherin and beta catenin immunoexpression in primary ovarian carcinomas an association with clinicopathological features

Ougolkov, A.; Mai, M.; Takahashi, Y.; Omote, K.; Bilim, V.; Shimizu, A.; Minamoto, T., 2000:
E-cadherin and beta-catenin are altered in early stage of gastric cancer

Herath, N.; Walsh, M.; Kew, M.; Young, J.; Leggett, B.; Macdonald, G.A., 2002:
E-cadherin and beta-catenin do not appear to be involved in hepatocarcinogenesis in Australia and South Africa

Bryden, A.A.G.; Hoyland, J.A.; Schembri Wismayer, D.; Freemont, A.J.; Clarke, N.W.; George, N.J.R., 2001:
E-cadherin and beta-catenin down regulation Factors in prostatic bone metastasis?

A.A.nati, M.M.; Riddell, R.H.; Tsao, M.S.und, 2004:
E-cadherin and beta-catenin expression changes in pancreatic intraepithelial neoplasia

Riding, M.A.; Wencyk, P.M.; Bell, J.A.; Ellis, I.O.; Elston, C.W.; Pinder, S.E., 2000:
E-cadherin and beta-catenin expression in breast cancer Is there change of expression with progression of disease?

Gill, R.; Sheffield, E.A., 2000:
E-cadherin and beta-catenin expression in follicular adenomas and well-differentiated thyroid carcinomas

Kemler, Rolf, 2001:
E-cadherin and beta-catenin in mouse development

Heatley, M.K., 2004:
E-cadherin and catenin expression in normal and neoplastic endocervical glandular epithelium

E.B.hrawy, M.; Talbot, I.; Poulsom, R.; Alison, M., 2000:
E-cadherin and catenin gene expression is markedly elevated in colorectal tumours from familial adenomatous polyposis patients

Bratthauer, G.L.; Tavassoli, F.A., 2001:
E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid intraepithelial neoplasias

Pasdar, M.; Wong, A.; Li, L.; Gilchrist, A., 2001:
E-cadherin and plakoglobin-mediated regulation of apoptosis in squamous carcinoma cell lines

Freitas, D.G.; Paik, S.H.; Han, K.R.u; Bui, M.H.; Nguyen, D.; Hernandez, J.M.; Caliliw, R.; Belldegrun, A.S., 2003:
E-cadherin based gene therapy A new purpose as an apoptotic inducer for kidney cancer

Qian, X.; Sheppard, A.; Vass, W.; Karpova, T.; Mcnally, J.; Lowy, D.R., 2003:
E-cadherin can inhibit activation of receptor tyrosine kinases and transformation by oncogenes

Carneiro, F.; Machado, J.C.; Seruca, R.; Sobrinho-Simões, M., 1999:
E-cadherin changes in gastric carcimona

Babb, S.G.; Marrs, J.A., 2001:
E-cadherin controls early cleavage patterns and is required for epiboly and gastrulation cell movements in early zebrafish embryos

Laux, H.W.lfgang; Kappler, R.; Hahn, H.; Schnitzbauer, U.; Hoefler, H.; Becker, K.F.iedrich, 2003:
E-cadherin defects activate a genetic program for tumor metastasis determined by cDNA microarray analysis

Laux, H.; Kappler, R.; Hahn, H.; Hoefler, H.; Becker, K.F., 2003:
E-cadherin dependent gene expression profiling in tumor cells using cDNA microarrays

Day, M.L.; Vallorosi, C.J.; Rashid, M.; Day, K.C.; Zhao, X.; Shah, R.; Amin, A.; Macoska, J.; Rubin, M.A., 2000:
E-cadherin down regulation in prostate carcinoma through post-translational protein truncation

Ong, A.; Maines Bandiera, S.; Roskelley, C.D.; Auersperg, N., 1999:
E-cadherin enhances the tumorigenic potential of human ovarian epithelial cells

Ozawa, Masayuki, 2002:
E-cadherin exists and functions as lateral dimers

Field, M.F.; Joslin, K.G., 2000:
E-cadherin expression and metastatic potential in a murine mammary tumor model

Harper, E.; Harrison, R.; Cooper, B.T.; Jankowski, J.A.Z.; Spychal, R.T., 2004:
E-cadherin expression does not appear to be modulated by TNF-alpha in an ex vivo model of Barretts metaplasia

D.S.batino, A.; Ciccocioppo, R.; Alvisi, C.; Luinetti, O.; Villani, L.; Ricevuti, L.; Tinozzi, F.P.; Corazza, G.R., 2000:
E-cadherin expression in Crohns disease

Pizarro, A., 2000:
E-cadherin expression in basal cell carcinoma: association with local invasiveness but not with metastatic inefficiency

Hajra, K.M.; Ji, X.; Fearon, E.R., 1999:
E-cadherin expression in breast cancer is extinguished by a dominant repression pathway

Rubin, M.A.; Figurski, J.; Mucci, N.R.; Manley, S.; Day, M.L., 2001:
E-cadherin expression in clinically localized and hormone refractory prostate carcinoma by use of high-density tissue microarrays Lack of correlation with tumor progression

Tsubokawa, R.; Hashikawa, T., 2003:
E-cadherin expression in developing rodent superior colliculus

Safdar, Z.; Bhattacharya, J., 2004:
E-cadherin expression in lung venular capillaries

Feirt, N.; Rush, D.; Hoda, S.; Soslow, R.A., 2000:
E-cadherin expression in mixed ductal and lobular carcinomas of the breast

Gamboa Dominguez, A.; Dominguez Fonseca, C.; Quintanilla Martinez, L.; Vargas, R.; Reyes Gutierrez, E.; Luber, B.; Becker, K.F.; Becker, I.; Hoefler, H.; Fend, F., 2003:
E-cadherin expression in sporadic gastric cancer from Mexico Exon 8 and 9 mutations detected by mutation-specific antibodies are an infrequent event associated with poor survival

Jungck, M.; Dernac, A.; Caspari, R.; Sauerbruch, T.; Ulrich, S., 1999:
E-cadherin expression is altered in normal mucosa of patients with familial adenomatous polyposis

Liu, Y.Q.; Hong, Y.; Eu, K.W.; Seow Choen, F., 2003:
E-cadherin expression is commonly downregulated by promoter methylation in colorectal cancer cell lines

Ross, J.S.; Sheehan, C.E.; Winn Deen, E.; Oliver, J.; Kallakury, B.V.S., 1999:
E-cadherin expression loss in prostate cancer is associated with hypermethylation of the E-cadherin promoter gene and amplification of the HER-2/neu oncogene

Machado, J.C.; Oliveira, C.; Carvalho, R.; Soares, P.; Berx, G.; Caldas, C.; Seruca, R.; Carneiro, F.; Sobrinho Simoes, M., 2001:
E-cadherin gene promoter methylation as the second genetic hit in sporadic diffuse gastric carcinoma

McColl, K.E.L.; El-Omar, E., 2002:
E-cadherin germline mutations and risk of gastric cancer

Oliveira, C.; Machado, J.C.; Carvalho, R.; Cameiro, F.; Seruca, R.; Caldas, C., 2001:
E-cadherin germline mutations in families with diffuse gastric cancer

Smits, R.; Ruiz, P.; Luz, A.; Fodde, R.; Diaz Cano, S.J., 2001 :
E-cadherin haploinsufficiency enhances Apc-driven tumorigenesis by apoptosis down-regulation in mouse models

Flora, R.; Ribeiro, U., J.; Zilberstein, B.; Lopes, L.H.C.; D.C.eva, R.; Safatle Ribeiro, A.V.; Gama Rodrigues, J., 2002:
E-cadherin immunoexpression in gastroesophageal reflux disease without Barretts esophagus

Chen, X.; Hoda, S.A.; Rosen, P.P., 2003:
E-cadherin immunostain distinguishes apocrine ductal carcinoma from apocrine lobular carcinoma

Wong, A.S.T.; Maines Bandiera, S.L.; Salamanca, M.C.; Roskelley, C.D.; Ong, A.; Auersperg, N., 2000:
E-cadherin in ovarian epithelial neoplasms Aberrant differentiation of a pleuripotential mesothelial precursor

Schwarte Waldhoff, I.; Mueller, N.; Michels, D.; Van Roy, F.; Schmiegel, W., 2001:
E-cadherin is a Smad4 target in colon carcinoma cells Evidence for a novel TGF-beta independent function of the tumor suppressor Smad4

Mueller, N.; Schwarte Waldhoff, I.; Michels, D.; Van Roy, F.; Schmiegel, W.H., 2001:
E-cadherin is a Smad4 target in colon carcinoma cells Evidence for novel TGF-beta independent functions of the tumor suppressor Smad4

Pereira, T.; Saad, R.S.; Liu, Y.L.; Tung, M.Y.; Landreneau, R.J.; Silverman, J.F., 2003:
E-cadherin is a useful immunohistochemical marker for differentiating benign from malignant mesothelial proliferations

Tobey, N.A.; Hosseini, S.S.; Orlando, R.C., 2002:
E-cadherin is important in the regulation of paracellular permeability in rabbit esophageal epithelium

Avizienyte, E.; Launonen, V.; Salovaara, R.; Kiviluoto, T.; Aaltonen, L.A., 2001:
E-cadherin is not frequently mutated in hereditary gastric cancer

Naritoku, W.Y.; Jones, L.; Taylor, C.R.; Imam, S.A., 2000:
E-cadherin is up-regulated by metastatic prostate cancer cells in bone

Qianming, C.; Kantak, S.; Qi, S.; Kramer, R.H., 2002:
E-cadherin junction formation induces activation of Erk1/2 signal pathway in oral squamous cell carcinoma cells

Kalish, R.S.; Ullman, Y.; Assy, B.; Shefer, Y.; Serafimovich, S.; Gilhar, A., 2003:
E-cadherin loss by keratinocytes differentiates psoriasiform dermatitis from psoriasis, and cutaneous T cell lymphoma

Angeletti, S.; Garcia Foncillas, J.; Okroujnov, I.; Martinez, M.J.; Jimenez, E.; Sureda, M.; Dicuonzo, G.; Brugarolas, A., 1999:
E-cadherin methylation in sporadic colorectal cancers

Fitzgerald, R.C.; Caldas, C., 2002:
E-cadherin mutations and hereditary gastric cancer: prevention by resection?

Wheeler, J.M.D.; Efstathiou, J.A.; Kim, H.C.; Beck, N.E.; Ilyas, M.; Mortensen, N.J.M.c.; Bodmer, W.F., 1999:
E-cadherin mutations in human colorectal cancer cell lines

Rocha, A.S.; Soares, P.; Machado, J.C.; Berx, G.; Maximo, V.; Sobrinho Simoes, M., 1999:
E-cadherin mutations in mucoepidermoid carcinoma of the thyroid

Harigopal, M.; Shin, S.J.; Rosen, P.P., 2003:
E-cadherin reliably distinguishes lobular and ductal carcinoma

Chunthapong, J.; Seftor, E.A.; Khalkhali Ellis, Z.; Sullivan, C.M.; Hendrix, M.J.C.; Heidger, P.M., 2003:
E-cadherin signaling in prostate cancer

Yap, A.S.; Ali, R.; Goodwin, M.; Mccormack, A.; Paterson, A.; Scott, J.; Kovacs, E.M., 2001:
E-cadherin signaling to the actin assembly machinery is necessary for dynamic adhesive recognition

Kovacs, E.M.; Ali, R.G.; Yap, A.S., 2002:
E-cadherin signaling to the actin cytoskeleton

Basse, D.; Goldstein, N.S.; Watts, J.C.; Layfield, L.J.; Yaziji, H.; Gown, A.M., 2001:
E-cadherin staining of non-invasive ductal and lobular lesions of the breast No evidence of a transition lesion

Gottardi, C.J.; Wong, E.; Gumbiner, B.M., 2001:
E-cadherin suppresses cellular transformation by inhibiting -catenin signaling in an adhesion-independent manner

Kuefer, R.; Day, K.C.; Rios Doria, J.; Gschwend, J.; Rubin, M.A.; Day, M.L., 2003:
E-cadherin truncation Sensitive tissue marker of metastatic progression of prostate cancer

Gardner, R.J.M., 1999:
E-cadherin unlikely to be a common low penetrance gene for colorectal cancer

Pavlou, G.; Jones, J.L.; Walker, R.A., 2000:
E-cadherin, alpha and beta-catenin and epidermal growth factor receptor in breast carcinomas

Kim, O.J.; Stemmermann, G.; Devoe, G.; Noffsinger, A.; Macdonald, J.; Fenoglio Preiser, C., 2001:
E-cadherin, alpha- and beta-catenins in gastric cancer expression

Clavel, C.; Nollet, F.; Berx, G.; Tejmar, S.; Nawrocki Raby, B.; Van Roy, F.; Birembaut, P., 2000:
E-cadherin- catenin adhesion complex involvement in neuroendocrine lung tumors

Wijnhoven, B.P.; Pignatelli, M., 1999:
E-cadherin-catenin: more than a "sticky" molecular complex

Ikesne, A.; Makagiansar, I.T.; Siahaan, T.J., 2001:
E-cadherin-derived EC-peptides as potential inhibitors for tumor invasion

Ougolkov, A.V.talievich; Yamashita, K.; Omote, K.; Takahashi, Y.; Mai, M.; Minamoto, T., 2001:
E-cadherin/beta-catenin expression in comparison with c-erbB-2 oncoprotein in advanced gastric cancer associated with liver metastasis

Vogelmann, R.; Wiest, S.; Philippi, C.; Seidel, B.; Adler, G.; Wedlich, D.; Menke, A., 1999:
E-cadherin/catenin mediated cell adhesion in pancreatic carcinoma cells

Auersperg, N.; Wong, A.S.T.; Leung, P.C.K., 2000:
E-cadherin/hepatocyte growth factor interactions in ovarian carcinogenesis

Eid, R.A.u; Mcguire, S.A., 1999:
E-evaluation of the indoor resuspension factor and other parameters for dose modeling analysis of decommissioning sites

Adams, Tadd, O., 2000:
E-fit monitor

Chiang, L.Y.; Anantharaj, V., 2003:
E-isomeric fullerene derivatives

Dewhurst, D., 2003:
E-learning support for undergraduate pharmacology teaching and learning

Kleber, K.; Holstein, J.; Schroeter, A.; Annacker, K.; Jaegermann, A.; Groenemeyer, D.H.W., 2000:
E-mail based image distribution with Jive

Mcmahon, S.R.; Iwamoto, M.; Massoudi, M.S.; Yusuf, H.R.; Stevenson, J.M.; Lebaron, C.W.; David, F.; Chu, S.Y.; Pickering, L.K., 2002 :
E-mail surveys-are we ready?

Stavis, Robert, 2002:
E-mail to parents from a computerized NICU documentation system

Abbey, L.; Joyce, D.; Aked, J.; Smith, B., 2001:
E-nose assessment of spring onions grown on two soils at three sulfur nutrition levels

Chong, B.; Murphy, J.; Kupper, T.S.; Fuhlbrigge, R.C., 2003:
E-selectin and ICAM-1 co-localize in mid to upper dermal vessels in non-inflamed human skin A means for cutaneous immunosurveillance

Giese, M.J.; Shum, D.; Munguia, M.; Rayner, S.; Mondino, B.J.; Berliner, J.A., 1999:
E-selectin and ICAM-1 expression in a rat model of Staphylococcus aureus endophthalmitis

Levin, J.D.; Ting Beall, H.P.; Hochmuth, R.M., 1999:
E-selectin and ICAM-1 expression on cytokine-stimulated microvascular endothelial cells Correlating structure and function

Warren, W.P.; Gautam, S.; Steen, H.; Lai, S.; Chatterjee, S.; Lima, J., 2003:
E-selectin and P-selectin are markers of aortic plaque burden as measured by transesophageal magnetic resource imaging

Gura, A.; Oygur, N.; Ongun, H.; Saka, O.; Yegin, O., 2003:
E-selectin as an early indicator and follow-up parameter in late neonatal sepsis

Fuhlbrigge, R.C.; Croce, K.; Robert, C.; King, S.L.; Merrill Skoloff, G.; Furie, B.; Furie, B.; Kupper, T.S., 2000:
E-selectin binding by dendritic cells is not dependent on expression of P-selectin glycoprotein ligand-1

Milstone, D.S.; Redline, R.W.; O'donnell, P.E.; Davis, V.M.; Stavrakis, G., 2000:
E-selectin expression and function at the fetal-maternal interface in placenta Regulation by a unique, trophoblast-restricted transcriptional mechanism conserved between humans and mice

Alpert, L.; Jamison, B.; Kontogiannea, M.; Dicarlo, A.; Tan, M.; Linjawi, A.; Metrakos, P.; Brodt, P., 2000:
E-selectin expression in hepatic blood vessels associated with colorectal carcinoma metastases

Kubo, M.; Takao, S.; Tokuda, K.; Uchikura, K.; Yoh, H.; Shinchi, H.; Aikou, T., 1999:
E-selectin expression on vascular endothelial cells, induced by carcinoma-derived cytokines, plays an important role in adhesion mechanism of highly metastasizing pancreatic cancer cells with sialyl Lewis a expression

Irurita, M.M.; Sanchez, F.; Loma Ossorio, A.; Canas, A.; Castaneda, A.; Irurita, J.; Lopez, L.; Deniz, C.; Saavedra, P.; Chirino, R.; Aros, F.; Iriarte, M., 2003:
E-selectin gene promoter is a predictor of outcome in unstable angina

Lipska, A.; Wysocka, J.; Stogowski, A.; Radziszewski, A., 2001:
E-selectin in patients with coronary heart disease

Chong, B.; Murphy, J.; Kupper, T.; Fuhlbrigge, R., 2001:
E-selectin is constitutively expressed by dermal blood vessels A targeting mechanism for skin-specific immunosurveillance by CLA+ memory T cells

Yu, Y.; Moulton, K.; Boye, E.; Davis, V.; Bischoff, J.; Milstone, D., 2002:
E-selectin is required for antiangiogenic activity of endostatin

Onozaki, A.; Sanada, H.; Midorikawa, S.; Imamura, N.; Hashimoto, S.; Watanabe, T., 2000:
E-selectin level may be a useful clinical marker for endothelial damage in hypertension

Hu, Y.; Kiely, J.M.rie; Gimbrone, M.A.J., 2003:
E-selectin mediates endothelial survival during inflammation

Storey, B.T.; Pittman, K.; Haisch, C.E.; Verbanac, K.M., 2003:
E-selectin mediates in vitro and in vivo adhesion of exogenous endothelial cells to tumor vasculature

Biondi, M.L.; Ghilardi, G.; Seminati, R.; Leviti, S.; Cecchini, F.; Odero, A.; Guagnellini, E., 2001:
E-selectin polymorphism and cardiovascular risk

Nimrichter, L.; Laroy, W.; Hudson, S.A.; Bochner, B.S.; Schnaar, R.L., 2002:
E-selectin-binding sialylated fucosylated glycosphingolipids from human neutrophils

Graefe, M.; Eschenhagen, P.; Henn, V.; Kroczek, R.A.; Graf, K.; Fleck, E., 1999:
E-selectin-dependent adhesion on leukocytes is induced by CD40-CD40 ligand interaction on human vascular endothelial cells

Hu, Y.; Kiely, J.M.; Szente, B.; Gimbrone, M.A.Jr, 1999:
E-selectin-dependent mitogen activated protein kinase activation and related events

Nuebel, T.; Kaina, B.; Fritz, G., 2004:
E-selectin-niediated tumor cell adhesion induced by gamma-rays is blocked by statins and retinoic acid

Smith,G.F.; Figueiredo,E., 2010:
E-taxonomy an affordable tool to fill the biodiversity knowledge gap

Danylyk, Donald Bohdan, 2004:
E-water machine

Mayrleitner, Martin, 1999:
E047/1 Antiarrhythmic

Braendle, E.; Bernt, U.; Kleinschmidt, K.; Hautmann, R.E., 1999:
E08 a specific inhibitor of the renal tubular oxalate secretion A new concept in the medical treatment of calcium-oxalate stones

Gordon, M.B.; Biller, B.M.K.; Vance, M.L.; Friend, K.; Azzalina, J., 2003:
E1 growth hormone dosing plateaus in growth hormone deficient men and women A KIMS-do preliminary data analysis

Ghany, M.G.; Kleiner, D.E., 2003:
E1 therapeutic vaccination for chronic hepatitis C: all that glitters is not gold

Barbu, A.R.; Welsh, N., 2002:
E1, E3 and E4-deleted adenoviral vectors induce necrosis in rat islet cells in vitro

Satoh, M.; Watanabe, N.; Hata, K.; Kitoh, K., 1999:
E1010, a new parenteral carbapenem In vitro and in vivo antipseudomonal activity

Ogunshola, O.; Antic, A.; Donoghue, M.J.; Madri, J.A.; Ment, L.R.; Stewart, W.B., 2000:
E15 mouse neurons express angiogenic factors in vitro

Chen, S.; Simons, S.S.oney, J., 2001:
E1A and E1A-associated proteins modulate GR-induced gene transactivation properties

Parreno, M.; Garriga, J.; Limon, A.; Mayol, X.; Beck, G.R.; Moran, E.; Grana, X., 2000:
E1A blocks hyperphosphorylation of p130 and p107 without affecting the phosphorylation status of the pRB

Zhou, Z.; Zhou, R.; Hung, M.C.ie; Kleinerman, E.S., 2001:
E1A down-regulated VEGF and MMP-9 expression in TC71 Ewings sarcoma cells

Shao, R.; Tsai, E.M.i; Makino, K.; Wei, K.; Von Lindern, R.; Yu, Z.; Hung, M.C.ie, 2001:
E1A mediates inhibition of radiation-induced NF-kappaB activity through suppression of IkappaB degradation independently of PKB/Akt activation

Voigtlander, C.; Rand, A.; Pittelkow, M.R.; Getz, M.J., 1999:
E1A represses tissue factor activity in highly metastatic melanoma cell lines

Jackson, M.; Carr, S.; Jacobs, S.C., 1999:
E1A- adenoviruses expressing Venezuelan equine encephalitis virus proteins protect against subcutaneous and aerosol challenge

Rosette, J.; Po, K.; Shindoh, M.; Higashino, F.; Yasuda, M.; Kohgo, T.; Totsuka, Y., 2002:
E1AF synergistically interacts with p53 resulting to an increase in p21waf1/cip1 activity and tumor suppression

Hata, H.; Izumiyama, Y.; Higashino, F.; Kohgo, T.; Shindoh, M., 2003:
E1AF, an ets-family transcription factor upregulates membrane-type1 matrix metalloproteinase that induces invasive/metastatic potential in malignant melanoma

Hiroumi, H.; Dosaka Akita, H.; Yoshida, K.; Shindoh, M.; Ohbuchi, T.; Mishina, T.; Hommura, F.; Ogura, S.; Kawakami, Y., 1999:
E1AF/PEA3, Ets-related transcriptional factor, in non-small cell lung cancer Its involvement in cell motile activity and frequent expression in resected tumors

Schneiders, A.M.; Schulz, M.; Leifeld, L.; Dueesberg, U.; Koopmann, J.; Matz, B.; Inchauspe, G.; Sauerbruch, T.; Spengler, U., 2000:
E2 antibodies mediate antibody dependent cellular cytotoxicity in HCV

Mukundan, H.; Resta, T.C.; Kanagy, N.L., 2003:
E2-beta attenuates hypoxic induction of EPO independent of increased NOS

Niidome, T.; Kimura, M.; Amino, H.; Komatsu, M.; Yamamoto, N.; Suzuki, Y.; IImura, Y.; Nishizawa, Y., 2001:
E2050, a novel neuronal calcium channel blocker, attenuates extracellular glutamate accumulation and subsequent neuronal injury induced by ischemia

Reiter, R.E.; Witte, O.N.; Sawyers, C.L., 2000:
E25a protein, methods for production and use thereof

Langerak, A.W.; Wolvers Tettero, I.L.M.; Van Gastel Mol, E.J.; Oud, M.E.C.M.; Van Dongen, J.J.M., 2000:
E2A and HEB induce immature T cell receptor gene rearrangements in non-lymphoid cells

Zhuang, Yuan; Pan, Lihua; Hanrahan, Jenifer; Li, Jie; Hale, Laura, P.; Zheng, Biao, 2001:
E2A plays both T-lineage intrinsic and extrinsic roles in T cell development

Kee, B.L.; Quong, M.W.; Murre, C., 2000:
E2A proteins: essential regulators at multiple stages of B-cell development

Kolanczyk, M.K.; Gantert, M.P.; Zemojtel, T.C.; Sykes, D.B.; Kamps, M.P.; Scheele, J.S., 2002:
E2A-Pbx1 Induced Target Gene Expression through LDSF Motif Dependent and Independent Mechanism in Fibroblasts and Murine Myeloid Precursor Cells

Gruenwald, S.; Sang, B C.; Monell, C., 1999:
E2A/PBX1 fusion protein specific monoclonal antibodies

Shibata, K.; Yamasaki, M.; Yoshida, T.; Mizukami, T., 2004:
E2F activity inhibitory compounds

Banerjee, D.; Bertino, J.R., 2002:
E2F and cancer chemotherapy

Suzuki, J.; Isobe, M.; Morishita, R.; Izawa, A.; Yamazaki, S.; Okubo, Y.; Kaneda, Y.; Sekiguchi, M., 1999:
E2F decoy suppresses E-selectin expression in murine cardiac allograft arteriopathy

Xiao, G.; Maclellan, R., 1999:
E2F regulates c-myc expression in ventricular cardiac myocytes

Dicker, A.J.; Popa, C.; Dahler, A.L.; Serewko, M.M.; Hilditch Maguire, P.A.; Frazer, I.H.; Saunders, N.A., 2000 :
E2F regulates keratinocyte proliferation and suppresses squamous differentiation

Lavia, P.; Jansen-Dürr, P., 1999:
E2F target genes and cell-cycle checkpoint control

Ferguson, K.L.; Callaghan, S.; Maclaurin, J.; O'hare, M.; Chaundy, K.; Park, D.S.; Slack, R.S., 1999:
E2F transcription factors are crucial regulators of neural precursor cell proliferation

Bernards, Rene, 2002:
E2F ubiquitination domain, and assays for inhibitors and enhancers of E2F ubiquitination

Hlaing, M.; Padmanabhan, K.; Cabezas, B.; Barker, C.; Bernstein, H.S., 2003:
E2F-1 activates a subset of target genes during the hypertrophic response in myoblasts

Nip, J.; Cleveland, J.L.; Zambetti, G.; Heibert, S.W., 1999:
E2F-1 and MDM-2 form distinct complexes with p53 in 32D3 myeloid progenitor cells

Huang, C.H.; Langer, C.J.; Zhang, S.Y.; Klein Szanto, A.J.P., 1999:
E2F-1 in stage I and II non-small cell lung cancer and its prognostic significance

Groves, M.D.; Lemoine, M.; Gomez Manzano, C.; Mitlianga, P.; Yung, W.K.A.fred; Fueyo, J., 2001:
E2F-1 increases the chemosensitivity of human glioma cells to temozolomide and BCNU

Conner, E.A.; Lemmer, E.M.; Sanderson, N.D.; Omori, M.; Thorgeirsson, S.S., 1999:
E2F-1 induced hepatocarcinogenesis in a transgenic mouse model

Li, T.; Regula, K.M.; Kirshenbaum, L.A., 2001:
E2F-1 mediated apoptosis of ventricular myocytes is suppressed by CrmA

Sharma, S.K.mar; Bair, K.W.; Chen, Y.N.n; Chen, W.; Clune, K.; Jiang, L.; Rogers, L.; Sabio, M.; Ramsey, T.M., 2001:
E2F-1/cyclin a antagonists Design, synthesis, and evaluation of a - -spirolactam library

Grassi, G.; Kuhn, A.; Schnorr, J.J.; Koehn, H.; Grassi, M.; Bauriedel, G.; Kandolf, R., 1999:
E2F1 and cyclin E directed ribozymes as a tool to inhibit smooth muscle cell proliferation after percutaneous transluminal angioplasty

Jordan Sciutto, K.L.; Brown, S.; Murray, B.; Wang, G.; Wiley, C.A.; Achim, C.L., 2000:
E2F1 and hyperphosphorylated Rb exhibit altered subcellular localization in models of HIVE

Sowers, R.; Toguchida, J.; Meyers, P.; Healey, J.; Huvos, A.; Banerjee, D.; Bertino, J.; Gorlick, R., 2002:
E2F1 correlates with DHFR, RFC and TS mRNA expression in osteosarcoma

Berton, T.R.; Mitchell, D.L.; Byrom, M.; Lowery, M.G.; Johnson, D.G., 2002:
E2F1 stimulates nucleotide excision repair and suppresses UVB-induced apoptosis

Vara, D.J.; Bicknell, K.A.; Head, K.; Seymour, A.M.rie; Brooks, G., 2002:
E2F3 plays a key role in cardiac myocyte growth

Deschenes, C.; Vezina, A.; Rivard, N., 2001:
E2F4 plays a much more important role than E2F1 in the promotion of cell cycle progression of human intestinal cells

Kurg, R.; Ilves, A.; Kaldalu, N.; Ustav, M., 2001:
E2Tag epitope tagging system for monitoring and purification of proteins

Baudis, M.; Smith, K.S.; Cleary, M.L., 2003:
E2a-Hlf down-regulates expression of the Interleukin-7 receptor alpha chain to impair the differentiation of B cell progenitors

Bijl, J.J.; Vacher, J.; Sauvageau, G., 2002:
E2a-PBX1 and Hoxb4 Are Collaborators in Human ALL

Wikonkal, N.M.; Remenyik, E.; Knezevic, D.; Zhang, W.; Liu, M.; Johnson, D.G.; Brash, D.E., 2004:
E2f1 is a pivotal regulator of UVB induced apoptosis and restores cancer resistance to Trp53-deficient mice

Nakajima, M.; Shimizu, H.; Kitami, N.; Suzuki, S.; Kojima, T.; Takei, Y.; Sato, N., 2001:
E3 binding protein of pyruvate dehydrogenase positivity correlate with progression of primary biliary cirrhosis

Kim, J.H.O.; Lee Kwon, W.; Cha, B.; Choi, J.W.ong; Donowitz, M., 2002:
E3KARP is involved in the Ca2+-dependent inhibition of Na+/H+ exchanger 3 through an ezrin-independent mechanism

Cha, B.Y.ung; Kim, J.H.e; Hut, H.; Kwon, W.L.e; Nadarajah, J.; Tse, M.; Cavet, M.; Yun, C.; Dejonge, H.; Donowitz, M., 2001:
E3KARP is necessary for cGMP regulation of NHE3 Demonstration of a plasma membrane signaling complex containing NHE3, E3KARP, and cGMP kinase II

Asai, T.; Baba, S.; Katsuya, T.; Fu, Y.; Inamoto, N.; Mannami, T.; Higaki, J.; Ogata, J.; Ogihara, T., 2001:
E4 allele of apolipoprotein gene was associated with lower blood pressure

Polat, M., 2002:
E4 allele of the apolipoprotein gene in Turkish patients with Alzheimers disease

Mccallum, R.W.; Petrie, J.R.; Dominiczak, A.F.; Connell, J.M.C., 2003:
E4 growth hormone reduces blood pressure and arterial stiffness in adult growth hormone deficient patients

Arranz, J.A.; Del Muro, X.G.rcia; Guma, J.; Aparicio, J.; Salazar, R.; Saenz, A.; Carles, J.; Sanchez, M.; Germa, J.R., 1999:
E400P in good prognosis advanced seminoma The Spanish germ-cell cancer group experience

Nguyen, D.H.ng; Frasca, D.; Sherwood, E.M.; King, A.M.; Riley, R.L.; Blomberg, B.B., 2002:
E47 transcription factor activity is down regulated in B lineage development in senescent mice

Cowell, I.G., 2002:
E4BP4/NFIL3, a PAR-related bZIP factor with many roles

Kim, S.H.eong; Song, S.H.un; Song, Y.C.ul; Chung, K.H.e; Seo, M.R.n; Juhnn, Y.S.ng; Bang, Y.J.e; Song, Y.S.ng, 2003:
E5 oncoprotein of human papillomavirus type 16 induces expression of cyclooxygenase-2 gene via signaling pathway of epidermal growth factor receptor

Toyosawa, T.; Kodama, K.; Suzuki, M.; Araki, S., 2003:
E5000 presents a new therapeutic strategy for sepsis and septic shock

Urbina, J.A.; Concepcion, J.L.; Sealey, M.R.; Caldera, A.R.; Payares, G.; Sanoja, C., 2003:
E5700 and ER-119884, novel quinuclidine orally active squalene synthase inhibitors In vitro and in vivo activities against Trypanosoma cruzi, the causative agent of Chagas disease

Huibregtse, J.M.; Scheffner, M.; Howley, P.M., 1999:
E6 associated protein

Band, V.; Gao, Q., 2002:
E6 targeted protein

Crish, J.; Bone, F.; Balasubramanian, S.; Zaim, T.; Wagner, T.; Yun, J.; Rorke, E.; Eckert, R., 1999:
E6/E7 mice - A model for human papillomavirus-dependent disease

Beer Romero, P.L.; Draetta, G.; Rolfe, M., 1999:
E6AP antisense constructs and methods of use

Van Dam, P.S.tze; Lijffijt, M.; Wittenberg, A.; D.V.ies, R.; D.W.nter, C.F.; Drent, M.L.; Van Der Grond, J.; Verbaten, M.N.; Kenemans, J.L.; Aleman, A.; D.H.an, E.H.F.; Koppeschaar, H.P.F., 2003:
E7 cognitive function, selective attention, event-related potentials and 1H magnetic resonance spectroscopy in childhood-onset growth hormone deficiency

Lee, S.; Rey, O.; Park, N.H.e, 2000:
E7 oncoprotein of human papillomavirus type-16 represses human fibronectin transcription

Matsui, J.; Obaishi, H.; Watanabe, T.; Yamaguchi, A.; Suzuki, S.; Yamamoto, Y.; Nakamura, K.; Nomoto, K.I.hi; Mimura, F.; Funahashi, Y.; Matsushima, T.; Miyazaki, K., 2003:
E7080, a novel VEGF receptor tyrosine kinase inhibitor-I Characterization as an angiogenesis inhibitor

Nakamura, K.; Yamamoto, Y.; Nomoto, K.I.hi; Matsui, J.; Mimura, F.; Obaishi, H.; Yamaguchi, A.; Suzuki, S.; Watanabe, T.; Funahashi, Y.; Matsushima, T.; Miyazaki, K., 2003:
E7080, a novel VEGF receptor tyrosine kinase inhibitor-II Effects on growth of human tumor xenografts and life span of mice in Colon 38 orthotopic transplantation model

Yamamoto, Yuji; Nakamura, Katsuji; Nomoto, Ken Ichi; Watanabe, Tatuso; Matsui, Junji; Obaishi, Hiroshi; Yamaguchi, Atsumi; Suzuki, Sachi; Mimura, Fusayo; Funahashi, Yasuhiro; Matsushima, Tomohiro; Miyazaki, Kazuki, 2003:
E7080, a novel VEGF receptor tyrosine kinase inhibitor-III Significant prolongation of life span in mice transplanted with human ovarian carcinoma based on inhibition of VEGF signaling

Kamath, K.; Okouneva, T.; Miller, H.; Davis, C.; Littlefield, B.A.; Wilson, L.; Jordan, M.A.n, 2003:
E7389, a synthetic analog of halichondrin B, suppresses microtubule dynamics in living MCF7 cells by a novel mechanism

Aimaretti, G.; Ambrosio, M.R.; Benvenga, S.; Borretta, G.; D.M.rinis, L.; D.M.nis, E.; D.S.mma, C.; Faustini Fustini, M.; Gasco, V.; Gasperi, M.; Scaroni, C.; Ghigo, E.; Giordano, G., 2003:
E8 screening of hypopituitarism in patients with traumatic brain injury

Gabel, M.; Mcevoy, D.; Fleming, C.; Tejwani, S.; Kloustin, K.; Javidan, J.; Peabody, J.; Stricker, H.; Demers, R.; Kim, J.; Menon, M., 2002:
E=MC2 A new formula for improving the prostate cancer patients care experience

Childers, W.E.J.; Abou Gharbia, M.A.; Moyer, J.A.; Zaleska, M.M., 2002:
EAA-090 Neuroprotectant competitive NMDA antagonist

Fan, M.Z.e; Matthews, J.C.; Burrin, D.G.; Lackeyram, D., 2003:
EAAC1 is the major high-affinity L-glutamate transporter and expression is upregulated during differentiation of neonatal porcine enterocytes

Sims, K.D.; Robinson, M.B., 1999:
EAAC1-mediated glutamate transport activity and cell surface expression in C6 glioma is regulated by two distinct kinase pathways

Martinowich, K.; Mendelowitz, D.S.; Williams, S.H.; Sutherland, M.L., 2001:
EAAT2 overexpression plays a neuroprotective role in models of temporal lobe epilepsy

Sutherland, M.L.; Martinowich, K.; Rothstein, J.D., 2001:
EAAT2 overexpression plays a neuroprotective role in the SOD1G93A model of amyotrophic lateral sclerosis

Poulsen, D.; Maragakis, N.J.; Hoke, A.; Snyder, E.Y.; During, M.J.; Rothstein, J.D., 2000:
EAAT2 transfected murine neural stem cells demonstrate glutamate uptake and are capable of engraftment in organotypic spinal cord cultures

Tzingounis, A.V.; Jackson, M.; Rothstein, J.D.; Kavanaugh, M.P., 2000:
EAAT4 is a high-affinity, low-capacity neuronal transporter

Pow, D.V.; Barnett, N.L.; Penfold, P.; Dayas, C., 1999:
EAAT5 A photoreceptor and bipolar cell glutamate transporter in rat retina?

Kuchroo, Vijay, K., 1999:
EAE and T-cell recognition of myelin proteolipid protein

Van Evercooren, A.S.B.ron; Picard, N.; Decker, L.; Goude, K.; Delarasse, C., 2001:
EAE elicits SVZ-derived oligodendrogenesis in adult mice

Jones, R.; Moes, N.; Mckeon, G.; Bourdette, D., 2002:
EAE in H-2s SCID mice induced by SJL T cells

Jones, R.; Moes, N.; Zamora, A.; Offner, H., 2002:
EAE in immunodeficient mice expressing a single transgenic TCR

Du, C.; Sriram, S., 2001:
EAE in lyn-deficient mice is not linked to the development of Th1 immune responses in CNS

Jones, R.E.; Moes, N.; Estrada, M.; Kitzerow, N.; Offner, H.; Vandenbark, A.; Whitham, R.; Bourdette, D., 2004:
EAE induced by allogeneic transplantation of myelin-specific Tg TCR T cells and T cell-deficient BMC in SCID mice

Shuzo, M.; Nagasawa, S.; Kanzaki, R.; Shimoyama, I., 2001:
EAG measurement of a free-walking silkworm moth with a wireless telemetry system

Heinemann, S.H.; Neef, A.; Loeber, K.; Schoenherr, R., 2000:
EAG potassium channels are voltage-dependent mechano transducers

Wilson, G.F.; Dimitratos, S.D.; Woods, D.F.; Lu, C.; Wang, Z.; Kreber, R.; Bryant, P.J.; Griffith, L.C.; Ganetzky, B., 2000:
EAG potassium channels associate with Camguk, the Drosophila homolog of the CASK/LIN-2 adaptor protein

Keyser, M.; Ganetzky, B.; Witten, J.L., 1999:
EAG potassium channels in the tobacco hornworm Developmental expression and cellular localization

Leng, Q.; Pei, H.; Watson, D.K.; Li, R., 2003:
EAPII interacts with Ets family members containing the PNT domain and represses the migration of epithelial cancer cells

Olmo,I.del; Lopez-Gonzalez,L.; Martin-Trillo,M.M.; Martinez-Zapater,J.M.; Pineiro,M.; Jarillo,J.A., 2010:
EARLY IN SHORT DAYS 7 encodes the catalytic subunit of DNA polymerase epsilon and is required for flowering repression through a mechanism involving epigenetic gene silencing

Gurbel, P.A.; Bahr, R.D.; Roe, M.T.; Serbruany, V.L.; Malinin, A.I.; Gibler, W.B.; Ohman, E.M., 2003:
EARLY platelet substudy

Adams, P.; Brissot, P.; Powell, L.W., 2000:
EASL International Consensus Conference on Haemochromatosis

Lynn, N.; Waymont, B.; Inglis, J.A.; Philp, N., 2002:
EAU guideline reduces unnecessary bone scans

Martinez-Mir, A.; Liu, J.; Gordon, D.; Weiner, M.S.; Ahmad, W.; Fine, J-David.; Ott, J.; Gilliam, T.Conrad.; Christiano, A.M., 2002:
EB simplex superficialis resulting from a mutation in the type VII collagen gene

Tao, Y.; Hu, Z.; Deng, X.; Tang, M.; Cao, Y.; Hu, G.; Wan, Y., 2002:
EB virus encoded latent membrane protein 1 modulates epidermal growth factor receptor phosphorylation and promoter activity in nasopharyngeal carcinoma cell line

Ernberg, Ingemar, 2001:
EB virus modulation of host cell function in latency and tumor risk

Ligon, L.A.; Shelly, S.; Tokito, M.; Holzbaur, E.L.F., 2001:
EB1 binds to the p150Glued subunit of dynactin and stabilizes microtubules in cultured epithelial cells

Bu, W.; Su, L.K.o, 2001:
EB1 family proteins associate with microtubules and induce microtubule bundling

Murthy, S.; Polek, T.C.; Ayala, G.; Weigel, N.L., 2001:
EB1089 arrests LNCaP tumors at an early stage of development and inhibits stromal recruitment in a nude mouse model

Narayanan, R.; Gaddy Kurten, D.; Montague, D.L.; Smith, C.L.; Weigel, N.L., 2000:
EB1089 preferentially stimulates osteoblastogenesis in bone marrow cultures of Sprague Dawley rats

Narayanan, R.; Smith, C.L.; Weigel, N.L., 1999:
EB1089 treatment partially reverses the reduction in vitamin D receptor activity in MG-63 cells subjected to simulated microgravity

Bruner Tran, K.L.; Tabibzadeh, S.; Comet, P.B.; Henriet, P.; Eisenberg, E.; Osteen, K.G., 2003:
EBAF/Lefty-1 antagonizes progesterone action in human endometrium and in experimental endometriosis

Ogushi, T.; Takahashi, S.; Fujimura, T.; Urano, T.; Ouchi, Y.; Kitamura, T.; Muramatsu, M.; Inoue, S., 2003:
EBAG9/RCAS1 expression is a negative prognostic predictor in patients with renal cell carcinoma

Okroujnov, I.; Garcia Foncillas, J.; Angeletti, S.; Martinez, M.J.; Jimenez, E.; Brugarolas, A., 1999:
EBC role in melanoma

Araneta, M.R.sario; Barrett Connor, E., 2003:
EBCT-defined subclinical coronary atherosclerosis in asymptomatic Filipina and Caucasian women

Peto, R., 2000:
EBCTCG Updated results from the September 2000 worldwide overview

Scharlemann, Jorn, P.W., 2003:
EBEAC Electronic Bulletin board for European Avian Curators

Horder, M.; Brandt, C.J.; Madsen, J.S., 1999:
EBM and education Contributions from the laboratory

Leight, E.R.; Sugden, B., 2000:
EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus

Zimber-Strobl, U.; Strobl, L.J., 2001:
EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes

Hayward, S.D.ane; Ling, P.D.lling, 2000:
EBNA2 peptides and methods of using same

Tolnay, M.; Vereshchagina, L.A.; Tsokos, G.C., 2002:
EBNA2 targets the human complement receptor 2 promoter through heterogeneous nuclear ribonucleoprotein D , and enhances promoter activity

D.P.olo, N.; Bocci, V.; Garosi, G.; Cappelletti, F.; Borrelli, E.; Aldinucci, C., 2000:
EBOO Preliminary report

Caro, J.J.ime; Huybrechts, K.F.; London, G.M., 2002:
EBT as a predictor of cardiovascular risk in patients on hemodialysis

Khanna, R.; Kerr, B.M.vis; Misko, I.S.ephan; Moss, D.J.mes; Burrows, S.R.nton, 2004:
EBV CTL epitopes

Raab Traub, N.; Harrelson, J.A.; Gulley, M.L., 2002:
EBV LMP 2A activates PI3K in vitro and in vivo

Yin, L.; Liao, W.; Deng, X.; Tang, M.; Gu, H.; Li, X.; Hu, Z.; Cao, Y., 2001:
EBV LMP1 activates NF-kappaB in nasopharyngeal carcinoma via phosphorylation and degradation of IkappaBalpha

Flinn, I.W.; Lemas, M.V.; Yang, J.; Murray, P.G.; Post, L.; Eby, L.; Fabian, D.; Noga, S.J.; Mann, R.B.; Krone, C.; Ma, H.; Cottler Fox, M.; Schwarz, K.; Colombani, P.M.; Orentas, R.J.; Ambinder, R.F., 1999:
EBV adoptive T cell therapy with partially HLA-matched donors is not associated with graft-versus-host disease

Young, L.S.; Dawson, C.W.; Eliopoulos, A.G., 1999:
EBV and apoptosis Viral amimicry of cellular pathways

Liao, W.; Tang, M.; Li, J.J.an; Lee, L.M.; Cao, Y., 2000:
EBV encoded latent membrane protein 1 increase expression of immunoglobulin kappa light chain through NF kappa B in nasopharyngeal carcinoma cell line

Cirocco, R.E.; Rodriguez, R.; Eloundou, I.; Burke, G.W.; Esquenazi, V.; Tzakis, A.; Miller, J., 2002:
EBV expansion in peripheral blood as an indication of immunosuppression in transplant recipients

Shulman, H.M.; Myerson, D., 1999:
EBV in necropsy lymphoid tissues after hematopoietic cell transplants

Cerutti, A.; Raab Traub, N.; Chadburn, A.; Schattner, E.J.; Knowles, D.K.; Casali, P.; He, B., 2003:
EBV induces Ig class switch DNA recombination and enhances malignant B cell growth and survival by up-regulating BAFF and APRIL through LMP1

Pagano, J.S.; Wakisaka, N., 2002:
EBV induces cellular invasiveness and metastasis factors

Marzec, B.; Kubiatowski, T.; Szczesniak, D.; Gawlowicz, M.; Wojcierowski, J., 2002:
EBV infected LCL human cells exhibit high expression of p53 gene

Guizzetti, M.; Spada, M.; Riva, S.; Melzi, M.L.isa; Segalin, A.; Lucianetti, A.; Bertani, A.; Peloni, G.; Petz, W.; Alberti, D.; Colledan, M.; Gridelli, B., 2000:
EBV infection after pediatric liver transplantation Methods for monitoring and therapeutical choices

Mihalik, R.; Petak, I.; Sebestyen, A.; Kopper, L.; Houghton, J.A., 2000:
EBV infection mediates resistance to death receptor- and TGF-beta1- induced apoptosis in B - cell lymphomas

Ernberg, I.; Chen, F.; Zou, J.Z.; Zhang, X.; Matskova, L.; Almqvist, J.; Berg, A.; Gish, G.; Ingham, R.; Sandberg, R.; Pawson, A.; Fu, H.L.; Winberg, G., 2002:
EBV latency control as a tumor risk factor

Bellas, C.; Santon, A.; Rico, M.L.; Cristobal, E.; Arribas, B.; Alvarez, E.; Menarguez, J., 1999:
EBV latent membrane protein oncogenic mutations in EBV-associated smooth muscle neoplasias

Brandau, O.; Schuster, V.; Weiss, M.; Strahm, B.; Hellebrand, H.; Schendel, D.; Niemeyer, C.; Belohradsky, B.H.; Meindl, A., 1999:
EBV negative patients with Non Hodgkin Burkitt Lymphoma have mutations in the SH2D1A gene as do patients with X-linked lymphoproliferative disease

Bengtson, P.O.of; Zetterberg, H.; Pahlsson, P.; Larson, G., 2003:
EBV transformed B cells from an individual homozygously mutated in the FUT7 gene do not roll on E- or P-selectins

Kumar, S.; Kingma, D.W.; Quintanilla Martinez, L.; Sorbara, L.; Raffeld, M.; Banks, P.M.; Jaffe, E.S., 1999:
EBV+ primary gastrointestinal Hodgkins disease Association with inflammatory bowel disease and immunosuppression

P.X.ongming; Shi Deren; Shen Dawei, 1999:
EBV, HHV-8 in tissue of Xinjiang Kaposis sarcoma An investigation of double infection

Malfitano, A.; Paulli, M.; Bruno, R.; Castelli, G.; Filice, G.; Minoli, L., 2000:
EBV, HHV-8, HCV and lymphomagenesis in HIV infection A study on the pavia cohort of HIV-associated lymphomas

Karanikiotes, C.; Vlachtsis, K.; Skiadas, I.; Georgakopoulou, S.; Karina, M.; Papandreou, S.; Georgakopoulos, E.; Fountzilas, G., 2003:
EBV-DNA in unfractionated whole blood specimens of patients with EBV-related diseases and seropositive healthy individuals

Van Bergen, A.H.; Hafemeyer, K.L.; Herrington, C.S.; Canter, C.E.; Braunlin, E.A., 2001:
EBV-PCR predicts susceptibility to post transplantation lymphoproliferative disease in pediatric heart transplant recipients

Emminger, C.; Wiemer, D.; S.F.oehlich; Jaeger, G., 2000:
EBV-Retinitis in a patient with AIDS A case report

Decaudin, D.; Marszak, F.B.ran; Couturier, J.; Martin, A.; Nemati, F.; Raphael, M.; Lantz, O.; D.S.nto, J.; Vincent Salomon, A.; Bordier, V.; Judde, J.G.briel; Poupon, M.F.ance, 2003:
EBV-associated human B-cell lymphoma obtained after Hodgkins xenograft in immunodeficient mice

Tinchon, C.; Auner, H.; Linkesch, W., 2000:
EBV-associated lymphoproliferative disease after therapy with fludarabine in AML

Tao, J.; Zhang, D.; Kahn, L.; Wasik, M.A., 2000:
EBV-associated polymorphic lymphoproliferative disorders in patients with different underlying immunodeficiency states A clinical-pathologic correlation study of 11 cases

Hewitt, S.M.; Kingma, D.W.; Merino, M.J.; Kleiner, D.E., 1999:
EBV-associated spindle cell tumors in HIV patients at autopsy

Zur Hausen, A.; Van Grieken, N.C.; Meijer, G.A.; Hermsen, M.A.; Meuwissen, S.G.; Baak, J.P.; Meijer, C.J.; Kuipers, E.J.; Van Den Brule, A.J., 2000:
EBV-carrying gastric carcinomas differ from EBV-negative gastric carcinomas with respect to distinct chromosomal alterations

Cerutti, A.; Raab Traub, N.; Casali, P.; He, B., 2003:
EBV-encoded LMP1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent immunoglobulin class switching

Tajima, M.; Takanashi, M.; Miyazawa, Y.; Takeshima, T.; Okinaga, K., 2001:
EBV-infected stomach cancer cell line

Lome Maldonado, C.; Martinez Benitez, B.; Valdes, S.; Lazo Langner, A.; Angeles Angeles, A., 2003:
EBV-positive anaplastic large cel lymphoma in Mexican patients

Juvonen, E.; Aalto, S.; Volin, L.; Hedman, K.; Ruutu, T., 2003:
EBV-qPCR positivity after allogeneic stem cell transplantation A retrospective study of the incidence and course without treatment in 407 patients

Hayashi, K.; Chen, H.Li; Koirala, T.R.; Ohara, N.; Teramoto, N.; Kondo, E.; Oka, T.; Ycshino, T.; Takahashi, K.; Miyamoto, K.; Akagi, T., 2000:
EBV-related herpesviruses from cynomolgus induce a high rate of rabbit T-cell lymphomas

Babel, N.; Kern, F.; Hoeflich, C.; Volk, H.D.; Reinke, P., 2000:
EBV-related monoclonal gammopathy in long term renal transplant patients is associated with activation of CD8+ T cells which may prevent development of B cell lymphoma

Ditting, T.; Geiger, H.; Groene, H.J.; Scheuermann, E.H.; Viertel, A.; Hauser, I.A., 1999:
EBV-related post transplant lymphoproliferation in a living related kidney transplant presenting as severe acute rejection A case report

Hansasuta, P.; Ogg, G.; Tan, L.; Gray, D.; Rahemetulla, A.; Hatton, C.; Rostron, T.; Mcmichael, A.J.; Rowland Jones, S., 1999:
EBV-specific CTL responses and the potential for cell therapy in EBV-related post-transplant lymphoproliferative disease

Johnson, K.J.; Mostafa, B.T.; Szmania, S.M.; Godder, K.; Chiang, K.Y.; Henslee Downey, P.J.; Van Rhee, F., 2000:
EBV-specific T-cell lines for adoptive transfer to PMRD allograft recipients

Webb, C.F.; Copeland, C.; Morrison, M.D.; Windeknecht, T.; Conley, M.E.len; Ly, D., 2003:
EBV-transformed cell lines from XLA patients express the transcription factor, bright

Tan, R.J.; Fattman, C.L.; Chang, L.Y.; Hanford, L.E.; Enghild, J.J.; Oury, T.D., 2002:
EC-SOD inhibits MMP-9 activation in a bleomycin model of pulmonary fibrosis

Ito, N.; Kawata, S.; Nakajima, H.; Tamura, S.; Kiso, S.; Saeki, A.; Oue, T.; Hanafusa, T.; Matsuzawa, Y., 1999:
EC2 domain of CD81 is strictly conserved in Japanese

Ni, X.; Gu, Y.; Niewiarowski, S.; Tuma, R.F., 2001:
EC3, a novel heterodimeric disintegrin from Echis carinatus venom, attenuates leukocyte/endothelial interactions

Huisman, W.; Kenny, D.; Burnett, D., 2001:
EC4 Essential Criteria as guide in the accreditation of medical laboratories using ISO/FDIS 15189

Gurr, E.; Zerah, S., 2001:
EC4 register of European clinical chemists Progress and status

Ruccolo, M.G.azia; Sasso, E.; Romero, M., 2000:
ECAMP project A population-based study of asthma with the collaboration of pharmacists and physicians

D.M.at, M.P.M.; Meijer, P.; Haverekate, F., 1999:
ECAT Foundation Quality assessment of assays in thrombophilia

Schoenberger, J.A.; Bergner, U.; Eilles, C., 1999:
ECAT versus ECAM, a comparison of two FDG imaging modalities

Arnold, F.H.; Shao, Z.; Zhao, H.; Giver, L.J., 2002:
ECB deacylase mutants

European Cancer Societies, 1999:
ECCO 10 The European Cancer Conference

Boutet, S.C.; Quertermous, T.; Fadel, B.M., 2000:
ECCO A novel transcription factor that regulates expression of angiogenic genes in endothelial cells

Fadel, B.M.; Boutet, S.C., 2000:
ECCO A novel vascular developmental transcription factor

Flynn, D.J.; Lundehn, J.R., 2003:
ECCO-peer review Development since 1996 and future prospects

Benti, R.; Antonini, A.; Zito, F.; Righini, A.; Zecchinelli, A.; Canesi, M.; Pezzoli, G.; Reschini, E.; Gerundini, P., 1999:
ECD brain SPECT and high-field MRI in the differential diagnosis between multiple system atrophy and Parkinsons disease

Mamede, M.; Ishizu, K.; Fujita, T.; Akita, Y.; Kitano, H.; Sadato, A.; Miyamoto, S.; Hashimoto, N.; Konishi, J., 2003:
ECD-ACZ SPECT studies with balloon test occlusion of bilateral vertebral arteries

Pillai, V.; Feigin, A.; Fukuda, M.; Antonini, A.; D.N.taris, R.; Benti, R.; Pezzoli, G.; Moeller, J.R.; Eidelberg, D., 2001:
ECD/SPECT in the differential diagnosis of parkinsonism

Nakamura, Y.; Saito, H., 1999:
ECDN protein and DNA encoding the same

Filippini, A.; Tripiciano, A.; Peluso, C.; Morena, A.R.; Stefanini Ziparo, M.; Palombi, F., 2000:
ECE-1 is cyclically expressed in Sertoli cells and mediates the spatiotemporal control of tubular contractility

Sarrif, A.M.; Aardema, M.J.; Albertini, S.; Arni, P.; Henderson, L.M.; Kirsch Volders, M.; Vrijhof, H., 2000:
ECETOC - EEMS symposium on dose-response and threshold-mediated mechanisms in mutagenesis General introduction

Bonilla, C.Y.; Olano, S.; Marquez Magana, L.M., 2002:
ECF sigmaY function in bacillus subtilis

Oba, Y.; Choi, S.J.; Roodman, G.D., 2002:
ECF-L is a critical co-factor for RANK ligand-induced osteoclastogenesis

Lin, Y.P.ng; Chen, C.H.an; Yu, W.C.ung; Hsu, T.L.eh; Ding, P.Y.A.; Yang, W.C.ang, 2002:
ECF/ICF is an independent determinant of large artery geometry and function in hemodialysis patients

Yang, I.F.ng; Yang, T.F.ng, 1999:
ECG QT dispersion in chronic renal failure patients before and after haemodialysis

Zhang, L.; Benson, D.W.odrow; Timothy, K.W.; Ptacek, L.J.; Tawil, R.; George, A.L.; Splawski, I.; Keating, M.T.; Chun, T.; Vincent, G.M.chael, 2003:
ECG T-U wave patterns predict genotype of Anderson syndrome patients with KCNJ2 mutations

Nasir, K.; Tufail, K.; Bomma, C.; Roguin, A.; Tandri, H.; Tichnell, C.; James, C.; Berger, R.; Halperin, H.; Crossan, J.; Spevak, P.; Calkins, H., 2003:
ECG and SAECG predictors of disease severity, VT induction and implantable defibrillator firing in arrhythmogenic right ventricle dysplasia

Martin, W.A.; Camenzind, E.; Burkhard, P.R., 2003:
ECG artifact due to deep brain stimulation

Kovtun, V.V.; Paulson, P.D., 2003:
ECG auto-gain control

Rajappan, K.; Mayet, J.; Rimoldi, O.; Camici, P.G.; Sheridan, D.J., 2001:
ECG changes and microcirculatory dysfunction in aortic valve stenosis

Zareba, W.; Moss, A.J.; Robinson, J.L., 2002 :
ECG changes in LQT1 and LQT2 carriers with borderline QTc duration